Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Effects Of Exercise Training With Dietary Restriction On Arterial Stiffness, Central Hemodynamic Parameters And Cardiac Autonomic Function In Obese Adolescents

Huang J, Lai Q, Wang D, Yin H, Liao J, Wang S, Xu F, Hou X, Hu M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2157-2163

Published Date: 17 October 2019

Jinmaitong Ameliorates Diabetic Peripheral Neuropathy Through Suppressing TXNIP/NLRP3 Inflammasome Activation In The Streptozotocin-Induced Diabetic Rat Model

Sun Q, Wang C, Yan B, Shi X, Shi Y, Qu L, Liang X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2145-2155

Published Date: 17 October 2019

Efficacy Of Acceptance And Commitment Therapy For Emotional Distress In The Elderly With Type 2 Diabetes: A Randomized Controlled Trial

Maghsoudi Z, Razavi Z, Razavi M, Javadi M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2137-2143

Published Date: 17 October 2019

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide

Simes BC, MacGregor GG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2125-2136

Published Date: 14 October 2019

Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome

Chen H, Xiong C, Shao X, Ning J, Gao P, Xiao H, Chen Y, Zou Z, Hong G, Li X, Shao M, Sheng J, Yang X, You X, Zou H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2117-2123

Published Date: 14 October 2019

Effects Of Saffron Supplementation On Inflammation And Metabolic Responses In Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Ebrahimi F, Sahebkar A, Aryaeian N, Pahlavani N, Fallah S, Moradi N, Abbasi D, Hosseini AF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2107-2115

Published Date: 14 October 2019

Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Induced Gestational Diabetes In Mice

Jiang YK, Xin KY, Ge HW, Kong FJ, Zhao G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2095-2105

Published Date: 14 October 2019

Original Research

Metabolic Syndrome Is Associated With Rapid Estimated Glomerular Filtration Rate Decline In A Chinese Community-Based Population

Wu Z, Jiang Y, Jia J, He D, Sun P, Li J, Huo Y, Fan F, Zhang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2085-2093

Published Date: 11 October 2019

A Novel Indicator Of Lipid Accumulation Product Associated With Metabolic Syndrome In Chinese Children And Adolescents

Zhang Y, Hu J, Li Z, Li T, Chen M, Wu L, Liu W, Han H, Yao R, Fu L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2075-2083

Published Date: 10 October 2019

Metabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease Patients

Chen YC, Hsu BG, Wang JH, Lee CJ, Tsai JP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2065-2073

Published Date: 8 October 2019

Exosomes from β-cells alleviated hyperglycemia and enhanced angiogenesis in islets of streptozotocin-induced diabetic mice

Sun Y, Mao Q, Shen C, Wang C, Jia W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2053-2064

Published Date: 8 October 2019

Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks

Shemesh E, Zafrir B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2041-2052

Published Date: 7 October 2019

The Relationship Between The Electromyographic Activity Of Rectus And Oblique Abdominal Muscles And Bioimpedance Body Composition Analysis - A Pilot Observational Study

Ptaszkowski K, Wlodarczyk P, Paprocka-Borowicz M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2033-2040

Published Date: 7 October 2019

A Retrospective Time Trend Study Of Diabetes Overtreatment In Geriatric Patients

Wojszel ZB, Kasiukiewicz A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2023-2032

Published Date: 4 October 2019

Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice

Rockwood S, Mason D, Lord R, Lamar P, Prozialeck W, Al-Nakkash L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2011-2021

Published Date: 3 October 2019

The Impact Of Hyperuricemia On Cardiometabolic Risk Factors In Patients With Diabetes Mellitus: A Cross-Sectional Study

Gaita L, Timar R, Lupascu N, Roman D, Albai A, Potre O, Timar B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2003-2010

Published Date: 3 October 2019

Potential role of phytochemicals in metabolic syndrome prevention and therapy

Francini-Pesenti F, Spinella P, Calò LA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1987-2002

Published Date: 1 October 2019

Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential

Bastin M, Andreelli F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1973-1985

Published Date: 30 September 2019

A Differential Diagnosis Model For Diabetic Nephropathy And Non-Diabetic Renal Disease In Patients With Type 2 Diabetes Complicated With Chronic Kidney Disease

Yang Z, Feng L, Huang Y, Xia N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1963-1972

Published Date: 30 September 2019

Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model

Gamede M, Mabuza L, Ngubane P, Khathi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1953-1962

Published Date: 1 October 2019

Multivariable Logistic Regression And Back Propagation Artificial Neural Network To Predict Diabetic Retinopathy

Yao L, Zhong Y, Wu J, Zhang G, Chen L, Guan P, Huang D, Liu L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1943-1951

Published Date: 25 September 2019

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis

Wan Z, Fan Y, Liu X, Xue J, Han Z, Zhu C, Wang X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1931-1942

Published Date: 20 September 2019

Serum CTRP3 Levels In Obese Children: A Potential Protective Adipokine Of Obesity, Insulin Sensitivity And Pancreatic β Cell Function

Chen T, Wang F, Chu Z, Shi X, Sun L, Lv H, Zhou W, Shen J, Chen L, Hou M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1923-1930

Published Date: 20 September 2019

Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia

Spooner KL, Guinan G, Koller S, Hong T, Chang AA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1913-1921

Published Date: 19 September 2019

A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

Rana K, Reid J, Rosenwasser JN, Lewis T, Sheikh-Ali M, Choksi RR, Goldfaden RF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1897-1911

Published Date: 19 September 2019

Aortic Stiffness Index And Carotid Intima-Media Thickness Are Independently Associated With The Presence Of Microalbuminuria In Patients With Type 2 Diabetes Mellitus

Turan Y, Turan E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1889-1896

Published Date: 19 September 2019

A Comparative Prevalence Of Metabolic Syndrome Among Type 2 Diabetes Mellitus Patients In Hawassa University Comprehensive Specialized Hospital Using Four Different Diagnostic Criteria

Bizuayehu Wube T, Mohammed Nuru M, Tesfaye Anbese A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1877-1887

Published Date: 19 September 2019

Does a diabetic retinopathy educational program raise awareness among elderly diabetic patients?

Khalaf FR, Fahmy HM, Ibrahim AK, Mohamed GA, El Sayed Ez Eldeen M, Elkady A, Hetta HF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1867-1875

Published Date: 20 September 2019

Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients

Derosa G, Pascuzzo MD, D'Angelo A, Maffioli P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1861-1865

Published Date: 18 September 2019

Lifestyle intervention for obesity: a call to transform the clinical care delivery system in Mexico

Díaz-Zavala RG, Candia-Plata MC, Martínez-Contreras TJ, Esparza-Romero J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1841-1859

Published Date: 13 September 2019

Original Research

Influence of genomic ancestry and self-reported color-race in CKD in a nationwide admixed sample of Brazilian patients with type 1 diabetes

Pizarro MH, Santos DC, Melo LGN, Barros BSV, Muniz LH, Porto LC, Silva DA, Gomes MB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1831-1840

Published Date: 12 September 2019

Association between metabolic syndrome and limb muscle quantity and quality in older adults: a pilot ultrasound study

Chang KV, Yang KC, Wu WT, Huang KC, Han DS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1821-1830

Published Date: 11 September 2019

Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy

Wang T, Gao Y, Wang X, Shi Y, Xu J, Wu B, He J, Li Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1811-1820

Published Date: 11 September 2019

Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome

Álvarez-Nava F, Racines M, Witt J, Guarderas J, Estévez M, Lanes R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1795-1809

Published Date: 9 September 2019

Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes

Ito H, Matsumoto S, Izutsu T, Kusano E, Nishio S, Antoku S, Yamasaki T, Mori T, Togane M, Ando S, Tsugami E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1783-1794

Published Date: 9 September 2019

High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense

Rangel Silvares R, Nunes Goulart da Silva Pereira E, Eduardo Ilaquita Flores E, Lino Rodrigues K, Ribeiro Silva A, Gonçalves-de-Albuquerque CF, Daliry A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1773-1781

Published Date: 6 September 2019

Attenuated serum 25-hydroxyvitamin D and vitamin D binding protein associated with cognitive impairment in patients with type 2 diabetes

Parveen R, Kapur P, Venkatesh S, Agarwal NB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1763-1772

Published Date: 9 September 2019

The effects of ginger supplementation on inflammatory, antioxidant, and periodontal parameters in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial

Zare Javid A, Bazyar H, Gholinezhad H, Rahimlou M, Rashidi H, Salehi P, Haghighi-zadeh MH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1751-1761

Published Date: 6 September 2019

The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study

Mahamid M, Khoury T, Mahamid B, Sbeit W, Mari A, Nseir W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1743-1749

Published Date: 4 September 2019

Original Research

Diagnostic accuracy of composite autonomic symptom scale 31 (COMPASS-31) in early detection of autonomic dysfunction in type 2 diabetes mellitus

Singh R, Arbaz M, Rai NK, Joshi R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1735-1742

Published Date: 5 September 2019

Association between new anthropometric parameters and arterial stiffness based on brachial-ankle pulse wave velocity

Choi HS, Cho YH, Lee SY, Park EJ, Kim YJ, Lee JG, Yi YH, Tak YJ, Hwang HR, Lee SH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1727-1733

Published Date: 3 September 2019

Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats

Mi J, He W, Lv J, Zhuang K, Huang H, Quan S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1717-1725

Published Date: 3 September 2019

Gross saponin of Tribulus terrestris improves erectile dysfunction in type 2 diabetic rats by repairing the endothelial function of the penile corpus cavernosum

Zhang H, Tong WT, Zhang CR, Li JL, Meng H, Yang HG, Chen M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1705-1716

Published Date: 2 September 2019

Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway

Li Z, Yang P, Liang Y, Xia N, Li Y, Su H, Pan H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1697-1703

Published Date: 3 September 2019

MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy

Zhang D, Li Z, Wang Z, Zeng F, Xiao W, Yu A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1685-1696

Published Date: 3 September 2019

Comparison of self-care in non-cardiac diabetic patients

Asghari F, Nobahar M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1675-1683

Published Date: 2 September 2019

Beneficial effects of Japanese sake yeast supplement on biochemical, antioxidant, and anti-inflammatory factors in streptozotocin-induced diabetic rats

Davoodi M, Karimooy FN, Budde T, Ortega-Martinez S, Moradi-Kor N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1667-1673

Published Date: 2 September 2019

Clinical Trial Report

Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study

Yakoot M, Abdelatif M, Helmy S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1659-1665

Published Date: 2 September 2019

IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway

Wu X, Yu T, Ji N, Huang Y, Gao L, Shi W, Yan Y, Li H, Ma L, Wu K, Wu Z

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1645-1657

Published Date: 29 August 2019

Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study

Alzahrani SH, Baig M, Aashi MM, Al-shaibi FK, Alqarni DA, Bakhamees WH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1639-1644

Published Date: 29 August 2019

Endoplasmic reticulum stress may be involved in insulin resistance and lipid metabolism disorders of the white adipose tissues induced by high-fat diet containing industrial trans-fatty acids

Zhu W, Niu X, Wang M, Li Z, Jiang HK, Li C, Caton SJ, Bai Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1625-1638

Published Date: 29 August 2019

Correlation analysis of metabolic syndrome and its components with thyroid nodules

Liu J, Wang C, Tang X, Fu S, Jing G, Ma L, Sun W, Li Y, Wu D, Niu Y, Niu Q, Guo H, Song P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1617-1623

Published Date: 30 August 2019

Regulation of alternative splicing in obesity-induced hypertension

Dlamini Z, Hull R, Makhafola TJ, Mbele M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1597-1615

Published Date: 28 August 2019

The effect of A1 adenosine receptor in diabetic megalin loss with caspase-1/IL18 signaling

Tian D, Shi X, Zhao Y, Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R, Chen L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1583-1596

Published Date: 28 August 2019

K-means clustering of overweight and obese population using quantile-transformed metabolic data

Li L, Song Q, Yang X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1573-1582

Published Date: 23 August 2019

An easily ignored factor for CAN-fine particulate exposure [Response to Letter]

Vasheghani M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1571-1572

Published Date: 23 August 2019

Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study

Ren R, Ma Y, Deng F, Li T, Wang H, Wei J, Jiang X, He M, Tian M, Liu D, Chen B, Deng W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1563-1569

Published Date: 22 August 2019

Empagliflozin in type 1 diabetes

Mathieu C, Van Den Mooter L, Eeckhout B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1555-1561

Published Date: 22 August 2019

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR

Ma S, Sun W, Gao L, Liu S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1543-1553

Published Date: 21 August 2019

Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes

Tang X, Yan X, Zhou H, Yang X, Niu X, Liu J, Ji Q, Ji L, Li X, Zhou Z

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1527-1541

Published Date: 28 August 2019

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Wang N, Yang T, Li J, Zhang X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1513-1526

Published Date: 22 August 2019

Impact of arterial hypertension and type 2 diabetes on cardiac autonomic modulation in obese individuals with recommendation for bariatric surgery

Carvalho NNC, de Oliveira Junior FA, da Silva G, Baccin Martins VJ, Braga VA, Costa-Silva JH, Fernandes Pimenta FC, de Brito Alves JL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1503-1511

Published Date: 21 August 2019

Comparison of the effect of two therapeutic exercises on the inflammatory and physiological conditions and complications of diabetic neuropathy in female patients

Nadi M, Bambaeichi E, Marandi SM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1493-1501

Published Date: 20 August 2019

Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice

Taketani H, Nishikawa T, Nakajima H, Kodo K, Sugimoto S, Aoi W, Horike S, Meguro-Horike M, Ishiba H, Seko Y, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Itoh Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1473-1492

Published Date: 23 August 2019

The relationship of mitochondrial dysfunction and the development of insulin resistance in Cushing’s syndrome

Ježková J, Ďurovcová V, Wenchich L, Hansíková H, Zeman J, Hána V, Marek J, Lacinová Z, Haluzík M, Kršek M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1459-1471

Published Date: 19 August 2019

Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride

Woodman OL, Ortega JM, Hart JL, Klein T, Potocnik S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1449-1458

Published Date: 16 August 2019

Linking the metabolic syndrome and obesity with vitamin D status: risks and opportunities for improving cardiometabolic health and well-being

Moukayed M, Grant WB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1437-1447

Published Date: 16 August 2019

Estrogen receptor inhibition enhances cold-induced adipocyte beiging and glucose tolerance

Lapid K, Lim A, Berglund ED, Lu Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1419-1436

Published Date: 14 August 2019

Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus

Bukhsh A, Khan TM, Sarfraz Nawaz M, Sajjad Ahmed H, Chan KG, Goh BH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1409-1417

Published Date: 14 August 2019

Skeletal muscle mass to visceral fat area ratio is an important determinant associated with type 2 diabetes and metabolic syndrome

Wang Q, Zheng D, Liu J, Fang L, Li Q

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1399-1407

Published Date: 14 August 2019

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]

Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1397-1398

Published Date: 14 August 2019

Prevalence and clinical characteristics of metabolically unhealthy obesity in an Iranian adult population

Rahmanian K, Shojaei M, Sotoodeh Jahromi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1387-1395

Published Date: 13 August 2019

Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus

Liang ZH, Jia YB, Li ZR, Li M, Wang ML, Yun YL, Yu LJ, Shi L, Zhu RX

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1379-1386

Published Date: 13 August 2019

Ambient air pollution exposure and obesity-related traits in Korean adults

Hwang SE, Kwon H, Jeong SM, Kim HJ, Park JH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1365-1377

Published Date: 9 August 2019

2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione isolated from Averrhoa carambola L. root ameliorates diabetic nephropathy by inhibiting the TLR4/MyD88/NF-κB pathway

Lu S, Zhang H, Wei X, Huang X, Chen L, Jiang L, Wu X, Zhou X, Qin L, Li Y, Lin X, Huang R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1355-1363

Published Date: 7 August 2019

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran

Shafie Pour MR, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1349-1354

Published Date: 7 August 2019

Impact of Ginkgo biloba extract and magnetized water on the survival rate and functional capabilities of pancreatic β-cells in type 2 diabetic rat model

Saleh A, Anwar MM, Zayed AE, Ezz Eldeen MES, Afifi G, Alnashiri HM, Gomaa AMS, Abd-Elkareem M, Abou-Elhamd AS, Shaheen ES, Mohamed GA, Hetta HF, Kotb AM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1339-1347

Published Date: 7 August 2019

Correlation of acidosis-adjusted potassium level and cardiovascular outcomes in diabetic ketoacidosis: a systematic review

Usman A, Makmor Bakry M, Mustafa N, Rehman IU, Bukhsh A, Lee SWH, Khan TM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1323-1338

Published Date: 6 August 2019

Empowerment of patients with type 2 diabetes: current perspectives

Gómez-Velasco DV, Almeda-Valdes P, Martagón AJ, Galán-Ramírez GA, Aguilar-Salinas CA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1311-1321

Published Date: 6 August 2019

A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation

Zhang C, Zhu X, Li L, Ma T, Shi M, Yang Y, Fan Q

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1297-1309

Published Date: 2 August 2019

Risk analysis of systemic levels of estrogen and adipokines as well as estrogen receptors from PBMCs in childbearing and perimenopausal women with obesity

Fan H, Chen S, Gao B, Ding S, Zhao Q, Li C, Asakawa T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1287-1295

Published Date: 1 August 2019

The association between omentin and diabetes: a systematic review and meta-analysis of observational studies

As´habi A, Sadeghi M, Arab A, Hajianfar H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1277-1286

Published Date: 31 July 2019

An easily ignored factor for CAN-fine particulate exposure [Letter]

Sun H, Liang M, Zheng N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1275-1276

Published Date: 31 July 2019

Decreased GFR and its joint association with type 2 diabetes and hypertension with prevalence and severity of carotid plaque in a community population in China

Che Q, Yang Y, Cheng G, Jia J, Fan F, Li J, Huo Y, Chen D, Zhang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1263-1273

Published Date: 26 July 2019

mRNAs expression profiles of high glucose-induced memory in human umbilical vein endothelial cells

Jin G, Wang Q, Pei X, Li X, Hu X, Xu E, Li M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1249-1261

Published Date: 23 July 2019

Association of salivary C-reactive protein with the obesity measures and markers in children

Selvaraju V, Babu JR, Geetha T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1239-1247

Published Date: 23 July 2019

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage

Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1225-1237

Published Date: 24 July 2019

Gene expression profiling reveals candidate biomarkers and probable molecular mechanism in diabetic peripheral neuropathy

Zhou H, Zhang W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1213-1223

Published Date: 23 July 2019

Plausible relationship between homocysteine and obesity risk via MTHFR gene: a meta-analysis of 38,317 individuals implementing Mendelian randomization

Fu L, Li Y, Luo D, Deng S, Hu YQ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1201-1212

Published Date: 23 July 2019

Diabetes care in public health facilities in India: a situational analysis using a mixed methods approach

Tripathy JP, Sagili KD, Kathirvel S, Trivedi A, Nagaraja SB, Bera OP, Reddy KK, Satyanarayana S, Khanna A, Chadha SS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1189-1199

Published Date: 19 July 2019

Metabolic factors that affect health-related quality of life in type 2 diabetes patients: a multivariate regression analysis

Dehesh T, Dehesh P, Gozashti MH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1181-1188

Published Date: 19 July 2019

A cross-sectional study of risk factors and hypertension among adolescent Senior High School students

Amponsem-Boateng C, Zhang W, Oppong TB, Opolot G, Kumi Duodu Kyere E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1173-1180

Published Date: 24 July 2019

Original Research

Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis

Lee K, Park IB, Yu SH, Kim SK, Kim SH, Seo DH, Hong S, Jeon JY, Kim DJ, Kim SW, Choi CS, Lee DH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1161-1171

Published Date: 16 July 2019

Osteoarthritis patients with high haemoglobin A1c have increased Toll-like receptor 4 and matrix metalloprotease-13 expression in the synovium

Murata K, Uchida K, Takano S, Shoji S, Iwase D, Inoue G, Aikawa J, Yokozeki Y, Sekiguchi H, Takaso M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1151-1159

Published Date: 16 July 2019

Impact of food pattern on glycemic control among type 2 diabetic patients: a cross-sectional study in the United Arab Emirates

Sadiya A, Mnla R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1143-1150

Published Date: 16 July 2019

Teneligliptin and “Thorough QTc study”: thorough enough?

Ghosal S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1141-1142

Published Date: 15 July 2019

Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study

Hadi Alijanvand M, Aminorroaya A, Kazemi I, Aminorroaya Yamini S, Janghorbani M, Amini M, Mansourian M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1123-1139

Published Date: 15 July 2019

Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus

Ogbonna SU, Ezeani IU, Okafor CI, Chinenye S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1113-1122

Published Date: 12 July 2019

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis

Hegazy MA, Samy MA, Tawfik A, Naguib MM, Ezzat A, Behiry ME

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1105-1111

Published Date: 11 July 2019

Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats

Qin Q, Lin N, Huang H, Zhang X, Cao X, Wang Y, Li P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1091-1103

Published Date: 10 July 2019

Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives

Rudland VL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1081-1089

Published Date: 10 July 2019

Smoking results in accumulation of ectopic fat in the liver

Kato A, Li Y, Ota A, Naito H, Yamada H, Nihashi T, Hotta Y, Chiang C, Hirakawa Y, Aoyama A, Tamakoshi K, Yatsuya H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1075-1080

Published Date: 9 July 2019

Genetic variants linked to T2DM risk in Kurdish populations [Retraction]

Golsheh S, Keshavarzi F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1073-1074

Published Date: 8 July 2019

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship

Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1057-1072

Published Date: 8 July 2019

Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment

Urakami T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1047-1056

Published Date: 8 July 2019

Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men

Taher R, Sara JD, Heidari B, Toya T, Lerman LO, Lerman A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1035-1045

Published Date: 5 July 2019

Sex disparities in the epidemic of type 2 diabetes in Mexico: national and state level results based on the Global Burden of Disease Study, 1990–2017

Dávila-Cervantes CA, Agudelo-Botero M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1023-1033

Published Date: 8 July 2019

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

Yang P, Liang Y, Luo Y, Li Z, Wen Y, Shen J, Li R, Zheng H, Gu HF, Xia N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1013-1021

Published Date: 4 July 2019

Review

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions

Gharaibeh NE, Rahhal MN, Rahimi L, Ismail-Beigi F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1001-1012

Published Date: 3 July 2019

Personalized intervention to improve stress and sleep patterns for glycemic control and weight management in obese Emirati patients with type 2 diabetes: a randomized controlled clinical trial

Mussa BM, Schauman M, Kumar V, Skaria S, Abusnana S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:991-999

Published Date: 28 June 2019

Replication of previous genome-wide association studies of HKDC1, BACE2, SLC16A11 and TMEM163 SNPs in a gestational diabetes mellitus case–control sample from Han Chinese population

Tan YX, Hu SM, You YP, Yang GL, Wang W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:983-989

Published Date: 27 June 2019

Identification of dynamic molecular networks in peripheral blood mononuclear cells in type 1 diabetes mellitus

Li L, Pan Z, Yang X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:969-982

Published Date: 25 June 2019

QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)

Erande S, Sarwardekar S, Desai B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:961-967

Published Date: 21 June 2019

Optimal management of diabetic foot osteomyelitis: challenges and solutions

Lázaro Martínez JL, García Álvarez Y, Tardáguila-García A, García Morales E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:947-959

Published Date: 21 June 2019

Prevalence and socio-behavioral factors associated with sugar-sweetened beverages consumption among 15 years and older persons in South Africa

Pengpid S, Peltzer K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:937-945

Published Date: 21 June 2019

Relationship between body-roundness index and metabolic syndrome in type 2 diabetes

Liu B, Liu B, Wu G, Yin F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:931-935

Published Date: 19 June 2019

Prognostic factors for cesarean section outcome of pregnant women with gestational diabetes mellitus: a systematic review and meta-analysis

Wang J, Chen K, Jin X, Li X, An P, Yang N, Chen Y, Fang Y, Mu Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:913-929

Published Date: 21 June 2019

Higher blood pressure increases arterial stiffness modified by blood glucose levels in a Chinese community-based study

Dai X, Yang Y, Cheng GL, Jia J, Fan FF, Li JP, Huo Y, Liu Z, Chen D, Zhang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:901-911

Published Date: 24 June 2019

Self-reported oral health and quality of life in patients with type 2 diabetes mellitus in primary care: a multi-center cross-sectional study

Verhulst MJL, Teeuw WJ, Gerdes VEA, Loos BG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:883-899

Published Date: 18 June 2019

GLP-1 mediates the modulating effect of thymoquinone on feeding behaviors in diabetic rats

Lee SP, Kuo FY, Cheng JT, Wu MC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:873-881

Published Date: 12 June 2019

Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women

Albracht-Schulte K, Rosairo S, Ramalingam L, Wijetunge S, Ratnayake RMCJ, Kotakadeniya HMSRB, Dawson JA, Kalupahana NS, Moustaid-Moussa N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:863-872

Published Date: 10 June 2019

Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia

Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, Zakri I, Sabai A, Darraj M, Mutawwam DA, Daghreeri M, Sayed S, Alaallah W, Alfadhly A, Alsabaani A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:853-862

Published Date: 5 June 2019

Current management strategies to target the increasing incidence of diabetes within Pakistan [Corrigendum]

Basit A, Fawwad A, Siddiqui SA, Baqa K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:851-852

Published Date: 4 June 2019

Validation and cross-cultural adaptation of the depression Patient’s Health Questionnaire – 9 in the Romanian population of patients with Type 2 Diabetes Mellitus

Lupascu N, Timar B, Albai A, Roman D, Potre O, Timar R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:841-849

Published Date: 30 May 2019

Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy

Jiang X, Yu J, Wang X, Ge J, Li N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:827-839

Published Date: 30 May 2019

Review

The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders

Mai BH, Yan LJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:821-826

Published Date: 27 May 2019

Obesity: outcome of standardized life-style change in a rehabilitation clinic. An observational study

Haslacher H, Fallmann H, Waldhäusl C, Hartmann E, Wagner OF, Waldhäusl WK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:813-820

Published Date: 27 May 2019

Original Research

Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis

Liu B, Mao X, Huang D, Li F, Dong N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:801-811

Published Date: 27 May 2019

Study Protocol

Mobile application intervention to promote self-management in insulin-requiring type 1 and type 2 diabetes individuals: protocol for a mixed methods study and non-blinded randomized controlled trial

Adu MD, Malabu UH, Malau-Aduli AEO, Malau-Aduli BS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:789-800

Published Date: 24 May 2019

Assessment of insulin sensitivity and secretion in patients with fibrocalculous pancreatic diabetes

Aiswarya Y, Shivaprasad C, Anish K, Sridevi A, Anupam B, Amit G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:779-788

Published Date: 22 May 2019

Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology

Li XY, Shen L, Ji HF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:771-778

Published Date: 17 May 2019

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea

Kunavisarut T, Sriussadaporn S, Lertwattanarak R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:761-770

Published Date: 21 May 2019

Original Research

Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study

Muo IM, MacDonald SD, Madan R, Park SJ, Gharib AM, Martinez PE, Walter MF, Yang SB, Rodante JA, Courville AB, Walter PJ, Cai H, Glicksman M, Guerrieri GM, Ben-Dor RR, Ouwerkerk R, Mao S, Chung JH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:743-759

Published Date: 27 May 2019

Immunogenetics of new onset diabetes after transplantation in Kuwait

Jahromi M, Al-Otaibi T, Othman N, Gheith O, Mahmoud T, Nair P, Halim MA, Nampoory N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:731-742

Published Date: 20 May 2019

Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis [Corrigendum]

Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:729-730

Published Date: 22 May 2019

The obstacles to diabetes self-management education and support from healthcare professionals’ perspectives: a nationwide survey

Preechasuk L, Sriussadaporn P, Likitmaskul S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:717-727

Published Date: 16 May 2019

Original Research

Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy

Ahmed AEA, Sakhr HM, Hassan MH, El-Amir MI, Ameen HH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:703-716

Published Date: 14 May 2019

Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction

Han Y, Ma Y, Liu Y, Zhao Z, Zhen S, Yang X, Xu Z, Wen D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:685-702

Published Date: 14 May 2019

The association of the fat mass and obesity-associated gene (FTO) rs9939609 polymorphism and the severe obesity in a Brazilian population

da Fonseca ACP, Abreu GM, Zembrzuski VM, Campos Junior M, Carneiro JRI, Nogueira Neto JF, Cabello GMK, Cabello PH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:667-684

Published Date: 23 May 2019

Downregulation of MALAT1 alleviates saturated fatty acid-induced myocardial inflammatory injury via the miR-26a/HMGB1/TLR4/NF-κB axis

Jia P, Wu N, Jia D, Sun Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:655-665

Published Date: 7 May 2019

Prevalence and correlates of underweight and overweight/obesity among women in India: results from the National Family Health Survey 2015–2016

Pengpid S, Peltzer K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:647-653

Published Date: 3 May 2019

An automatic diagnostic system based on deep learning, to diagnose hyperlipidemia

Zhang Q, Liu Y, Liu G, Zhao G, Qu Z, Yang W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:637-645

Published Date: 3 May 2019

MRI assessment of ectopic fat accumulation in pancreas, liver and skeletal muscle in patients with obesity, overweight and normal BMI in correlation with the presence of central obesity and metabolic syndrome

Pieńkowska J, Brzeska B, Kaszubowski M, Kozak O, Jankowska A, Szurowska E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:623-636

Published Date: 3 May 2019

Eight-week of low-intensive lifestyle modification does improve insulin resistance in adults with metabolic syndrome

Lin YH, Huang H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:613-621

Published Date: 2 May 2019

Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients

Bakr Zaki M, Abulsoud AI, Elsisi AM, Doghish AS, Mansour OAE, Amin AI, Elrebehy MA, Mohamed MY, Goda MA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:601-611

Published Date: 6 May 2019

Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study

Rezaei M, Valiee S, Tahan M, Ebtekar F, Ghanei Gheshlagh R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:589-599

Published Date: 1 May 2019

The association between cardiac autonomic neuropathy and diabetes control

Vasheghani M, Sarvghadi F, Beyranvand MR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:581-587

Published Date: 30 April 2019

Prevalence of metabolic syndrome in dialysis and transplant patients

AlShelleh S, AlAwwa I, Oweis A, AlRyalat SA, Al-Essa M, Saeed I, Alhawari HH, Alzoubi KH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:575-579

Published Date: 29 April 2019

Anti-inflammatory and angiogenic effects of exercise training in cardiac muscle of diabetic mice

Broderick TL, Sennott JM, Gutkowska J, Jankowski M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:565-573

Published Date: 26 April 2019

Clinical effectiveness of quercetin supplementation in the management of weight loss: a pooled analysis of randomized controlled trials

Huang H, Liao D, Dong Y, Pu R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:553-563

Published Date: 24 April 2019

Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach

Frost F, Dyce P, Ochota A, Pandya S, Clarke T, Walshaw MJ, Nazareth DS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:545-552

Published Date: 26 April 2019

The relationship between hypertriglyceridemic-waist phenotype and vitamin D status in type 2 diabetes

Ma CM, Yin FZ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:537-543

Published Date: 23 April 2019

Cardiovascular risk profile, oxygen uptake, and perceived exertion rate in children with obesity: the interactive effect of exercise intensity and duration

Elnaggar RK, Elshazly FA, Abdelbasset WK, Ahmed AS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:527-536

Published Date: 17 April 2019

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Xie J, Li N, Jiang X, Chai L, Chen JJ, Deng W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:519-526

Published Date: 17 April 2019

Association between lipid accumulation product and diabetic retinopathy based on a community-based survey in Chinese with type 2 diabetes

Wu J, Zhong Y, Yue S, Guan P, Zhang G, Liu L, Chen L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:513-518

Published Date: 16 April 2019

Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date

Howell R, Wright AM, Clements JN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:505-512

Published Date: 17 April 2019

Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease

Shida T, Oshida N, Oh S, Okada K, Shoda J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:495-503

Published Date: 15 April 2019

Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers

Zahran AM, Sayed SK, Abd El Hafeez HA, Khalifa WA, Mohamed NA, Hetta HF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:485-493

Published Date: 12 April 2019

Original Research

Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis

Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:477-484

Published Date: 11 April 2019

Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects

Shin D, Eom YS, Chon S, Kim BJ, Yu KS, Lee DH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:469-476

Published Date: 10 April 2019

Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia

Luo Y, Bajoria R, Lai Y, Pan H, Li Q, Zhang Z, Yang P, Chatterjee R, Liang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:457-468

Published Date: 11 April 2019

Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials

Hinnen D, Kruger DF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:447-455

Published Date: 4 April 2019

Low-dose computed tomography of urolithiasis in obese patients: a feasibility study to evaluate image reconstruction algorithms

Chang DH, Slebocki K, Khristenko E, Herden J, Salem J, Große Hokamp N, Mammadov K, Hellmich M, Kabbasch C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:439-445

Published Date: 5 April 2019

Genetic variants linked to T2DM risk in Kurdish populations

Golsheh S, Keshavarzi F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:431-437

Published Date: 5 April 2019

Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions

Kratochvilova H, Lacinova Z, Klouckova J, Kavalkova P, Cinkajzlova A, Trachta P, Krizova J, Benes M, Dolezalova K, Fried M, Vlasakova Z, Pelikanova T, Spicak J, Mraz M, Haluzik M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:423-430

Published Date: 28 March 2019

Effects of polymorphism in FABP2 Ala54Thr on serum lipids and glycemic control in low glycemic index diets are associated with gender among Han Chinese with type 2 diabetes mellitus

Liu PJ, Liu YP, Qin HK, Xing T, Li SS, Bao YY

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:413-421

Published Date: 27 March 2019

Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4

Zhao H, Shu L, Huang W, Song G, Ma H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:401-411

Published Date: 25 March 2019

Factors associated with overweight and obesity among adults in northeast Ethiopia: a cross-sectional study

Dagne S, Gelaw YA, Abebe Z, Wassie MM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:391-399

Published Date: 22 March 2019

Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus

Elsehmawy AAEW, El-Toukhy SE, Seliem NMA, Moustafa RS, Mohammed DS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:383-389

Published Date: 22 March 2019

Increase in mast cell marker expression in the synovium of obese patients with osteoarthritis of the knee

Uchida K, Takano S, Inoue G, Iwase D, Aikawa J, Takata K, Tazawa R, Kawakubo A, Sekiguchi H, Takaso M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:377-382

Published Date: 21 March 2019

Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study

Talwalkar P, Deshmukh V, Bhole M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:369-376

Published Date: 20 March 2019

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease

Szanto KB, Li J, Cordero P, Oben JA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:357-367

Published Date: 19 March 2019

The role of concordant and discordant comorbidities on performance of self-care behaviors in adults with type 2 diabetes: a systematic review

Aga F, Dunbar SB, Kebede T, Gary RA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:333-356

Published Date: 18 March 2019

Galectin-3 as a prognostic biomarker for diabetic nephropathy

Hodeib H, Hagras MM, Abdelhai D, Watany MM, Selim A, Tawfik MA, Elsebaey MA, Elshweikh SA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:325-331

Published Date: 13 March 2019

Original Research

Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease

Soleimani D, Ranjbar G, Rezvani R, Goshayeshi L, Razmpour F, Nematy M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:315-324

Published Date: 12 March 2019

The relationship between serum-free insulin-like growth factor-1 and metabolic syndrome in school adolescents of northeast China

Xie S, Jiang R, Xu W, Chen Y, Tang L, Li L, Li P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:305-313

Published Date: 5 March 2019

Case Series

Optimizing glycemic control in type 2 diabetic patients through the use of a low-carbohydrate, high-fat, ketogenic diet: a review of two patients in primary care

Rallis S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:299-303

Published Date: 5 March 2019

Measurement of diabetes, prediabetes and their associated risk factors in Myanmar 2014

Latt TS, Zaw KK, Ko K, Hlaing MM, Ohnmar M, Oo ES, Thein KMM, Yuasa M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:291-298

Published Date: 4 March 2019

Case report

Diabetic muscle infarction: often misdiagnosed and mismanaged

Verjee MA, Abdelsamad NA, Qureshi S, Malik RA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:285-290

Published Date: 5 March 2019

Original Research

ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity

Vincent V, Thakkar H, Aggarwal S, Mridha AR, Ramakrishnan L, Singh A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:275-284

Published Date: 25 February 2019

Morbidity associated with overweight and obesity in health personnel: a 10-year retrospective of hospital-based cohort study in Taiwan

Yeh TL, Chen HH, Chiu HH, Chiu YH, Hwang LC, Wu SL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:267-274

Published Date: 7 March 2019

Identification of the MC4R start lost mutation in a morbidly obese Brazilian patient

Fonseca ACP, Abreu GM, Zembrzuski VM, Campos Junior M, Carneiro JRI, Magno FCCM, Rosado EL, Nogueira Neto JF, Cabello GMK, Cabello PH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:257-266

Published Date: 21 February 2019

Interaction between dietary patterns and TCF7L2 polymorphisms on type 2 diabetes mellitus among Uyghur adults in Xinjiang Province, China

Cai J, Zhang Y, Nuli R, Zhang Y, Abudusemaiti M, Kadeer A, Tian X, Xiao H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:239-255

Published Date: 14 February 2019

PEARLS randomized lifestyle trial in pregnant Hispanic women with overweight/obesity: gestational weight gain and offspring birthweight

Trak-Fellermeier MA, Campos M, Meléndez M, Pomeroy J, Palacios C, Rivera-Viñas J, Méndez K, Febo I, Willett W, Gillman MW, Franks PW, Joshipura K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:225-238

Published Date: 18 February 2019

Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats

Mabuza LP, Gamede MW, Maikoo S, Booysen IN, Ngubane PS, Khathi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:217-223

Published Date: 14 February 2019

Canagliflozin review – safety and efficacy profile in patients with T2DM

Jakher H, Chang TI, Tan M, Mahaffey KW

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:209-215

Published Date: 1 February 2019

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis

Sun Y, Dai W, Liang Y, Yang P, Yang Q, Liang M, Xia N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:199-207

Published Date: 30 January 2019

Leptin resistance: underlying mechanisms and diagnosis

Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:191-198

Published Date: 25 January 2019

The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010–2011

Khang AR, Lee HW, Yi DW, Kang YH, Son SM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:181-190

Published Date: 24 January 2019

Effect of kiwifruit on metabolic health in patients with cardiovascular risk factors: a systematic review and meta-analysis

Suksomboon N, Poolsup N, Lin W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:171-180

Published Date: 23 January 2019

Analysis of the diet quality and dietary habits of children and adolescents with type 1 diabetes

Dłużniak-Gołaska K, Panczyk M, Szostak-Węgierek D, Szypowska A, Sińska B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:161-170

Published Date: 17 January 2019

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats

Yu HH, Hsieh MC, Wu SY, Sy ED, Shan YS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:149-159

Published Date: 17 January 2019

Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people

Xin YL, Wang Y, Chi J, Zhu X, Zhao H, Zhao S, Wang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:139-147

Published Date: 17 January 2019

Metabolic syndrome as a risk factor for high intraocular pressure: the Korea National Health and Nutrition Examination Survey 2008–2010

Yi YH, Cho YH, Kim YJ, Lee SY, Lee JG, Kong EH, Cho BM, Tak YJ, Hwang HR, Lee SH, Park EJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:131-137

Published Date: 14 January 2019

Different risk factors for cognitive impairment among community-dwelling elderly, with impaired fasting glucose or diabetes

Xiu S, Zheng Z, Liao Q, Chan P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:121-130

Published Date: 9 January 2019

Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes

Durán AM, Salto LM, Câmara J, Basu A, Paquien I, Beeson WL, Firek A, Cordero-MacIntyre Z, De León M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:109-120

Published Date: 8 January 2019

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice

Campbell CL, Yu R, Li F, Zhou Q, Chen D, Qi C, Yin Y, Sun J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:97-107

Published Date: 4 January 2019

Current management strategies to target the increasing incidence of diabetes within Pakistan

Basit A, Fawwad A, Siddiqui SA, Baqa K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:85-96

Published Date: 27 December 2018

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia

Fasil A, Biadgo B, Abebe M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:75-83

Published Date: 21 December 2018

Comparison of three meta-analytic methods using data from digital interventions on type 2 diabetes

Kebede MM, Peters M, Heise TL, Pischke CR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:59-73

Published Date: 19 December 2018

Physical activity increases the resistin concentration in hemodialyzed patients without metabolic syndrome

Hornik B, Duława J, Szewieczek J, Durmała J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:43-57

Published Date: 18 December 2018

Initial outcomes of one anastomosis gastric bypass at a single institution

Jamal W, Zagzoog MM, Sait SH, Alamoudi AO, Abo’ouf S, Alghamdi AA, Bamashmous RO, Maghrabi AA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:35-41

Published Date: 24 December 2018

Psychosocial interventions for reducing diabetes distress in vulnerable people with type 2 diabetes mellitus: a systematic review and meta-analysis

Mathiesen AS, Egerod I, Jensen T, Kaldan G, Langberg H, Thomsen T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:19-33

Published Date: 17 December 2018

Self-management knowledge and practice of type 2 diabetes mellitus patients in Baghdad, Iraq: a qualitative study

Mikhael EM, Hassali MA, Hussain SA, Shawky N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1-17

Published Date: 17 December 2018

Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report

Cheng KC, Li Y, Chang WT, Kuo FY, Chen ZC, Cheng JT

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:901-911

Published Date: 7 December 2018

Salubrinal abrogates palmitate-induced leptin resistance and endoplasmic reticulum stress via nuclear factor kappa-light-chain-enhancer of activated B cell pathway in mHypoE-44 hypothalamic neurons

Zhang M, Jiang X, Qu M, Gu H, Sha Q, Hua F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:893-899

Published Date: 6 December 2018

Serum trace elements in insulin-dependent and non-insulin-dependent diabetes: a comparative study

Ahmed AM, Khabour OF, Awadalla AH, Waggiallah HA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:887-892

Published Date: 4 December 2018

Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis

Huang H, Chi H, Liao D, Zou Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:875-886

Published Date: 29 November 2018

Original Research

Genistein diet does not modify crypt morphology in the ob/ob mouse jejunum: a comparison of cryostat and clearing techniques

Sandoval-Skeet N, Kaufman JA, Castro MJ, Al-Nakkash L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:863-873

Published Date: 29 November 2018

Commentary

A paradigm shift for the prevention and treatment of individual and global obesity

Slyper AH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:855-861

Published Date: 29 November 2018

Review

TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?

Dar MS, Bég SA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:845-853

Published Date: 28 November 2018

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis

Seko Y, Nishikawa T, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Kimura M, Iijima H, Hashimoto T, Sumida Y, Okanoue T, Itoh Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:835-843

Published Date: 27 November 2018

Dysfunctional phagocytosis capacity, granulocyte recruitment and inflammatory factor secretion of Kupffer cells in diabetes mellitus reversed by Lidocaine

Wang R, Sheng M, Shi F, Zhao Y, Zhao L, Wu J, Wu G, Song Q

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:827-834

Published Date: 26 November 2018

Madelung’s disease – progressive, excessive, and symmetrical deposition of adipose tissue in the subcutaneous layer: case report and literature review

Szewc M, Sitarz R, Moroz N, Maciejewski R, Wierzbicki R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:819-825

Published Date: 26 November 2018

Early detection of metabolic dysregulation using water T2 analysis of biobanked samples

Mishra I, Jones C, Patel V, Deodhar S, Cistola DP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:807-818

Published Date: 23 November 2018

Original Research

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Funch D, Mortimer K, Li L, Norman H, Major-Pedersen A, Olsen AH, Kaltoft MS, Dore DD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:791-806

Published Date: 22 November 2018

Diets high in vegetables, fruits, cereals, and tubers as a protective factor for metabolic syndrome in bank employees

Cattafesta M, Salaroli LB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:781-790

Published Date: 21 November 2018

Examining the association between diabetes, depressive symptoms, and suicidal ideation among Aboriginal Canadian peoples living off-reserve: a cross-sectional, population-based study

Elamoshy R, Bird Y, Thorpe LU, Moraros J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:767-780

Published Date: 22 November 2018

An epidemiologic study on symptomatic pelvic organ prolapse in obese Chinese women: a population-based study in China

Li Z, Xu T, Li Z, Gong J, Liu Q, Wang Y, Wang J, Xia Z, Zhu L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:761-766

Published Date: 16 November 2018

Long-term outcomes following completion of a structured nutrition and exercise lifestyle intervention program for patients with metabolic syndrome

Joseph MS, Konerman MA, Zhang M, Wei B, Brinza E, Walden P, Jackson EA, Rubenfire M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:753-759

Published Date: 15 November 2018

Relationship between early menarche, obesity, and disordered eating behaviors: a school-based cross-sectional survey in Northern Saudi Arabia

Almuhlafi M, Abu Jamilah K, Almutairi AF, Salam M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:743-751

Published Date: 15 November 2018

Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure

Huang H, Liao D, Pu R, Cui Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:729-742

Published Date: 14 November 2018

Original Research

Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study

Ahmadieh H, Itani H, Itani S, Sidani K, Kassem M, Farhat K, Jbeily M, Itani A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:717-728

Published Date: 8 November 2018

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

Conway BN, Badders AN, Costacou T, Arthur JM, Innes KE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:707-716

Published Date: 15 November 2018

Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action

Firouzi S, Malekahmadi M, Ghayour-Mobarhan M, Ferns G, Rahimi HR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:699-705

Published Date: 8 November 2018

COSMIC project: consensus on the objectives of the metabolic syndrome in clinic

Pedro-Botet J, Ascaso JF, Barrios V, De la Sierra A, Escalada J, Millan J, Mostaza JM, Pérez-Martínez P, Pintó X, Salas-Salvadó J, Valdivielso P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:683-697

Published Date: 31 October 2018

Astragalus polysaccharides inhibit oxidation in high glucose-challenged or SOD2-silenced H9C2 cells

Chen W, Sun Q, Ju J, Chen W, Zhao X, Zhang Y, Yang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:673-681

Published Date: 24 October 2018

Influence of gastric bypass surgery on resting energy expenditure, body composition, physical activity, and thyroid hormones in morbidly obese patients

Mirahmadian M, Hasani M, Taheri E, Qorbani M, Hosseini S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:667-672

Published Date: 23 October 2018

Original Research

Depressive symptoms among elderly diabetic patients in Vietnam

Vu HTT, Nguyen TX, Nguyen HTT, Le TA, Nguyen TN, Nguyen AT, Nguyen TTH, Nguyen HL, Nguyen CT, Tran BX, Latkin CA, Pham T, Zhang MW, Ho RC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:659-665

Published Date: 23 October 2018

Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus

Gouda M, Matsukawa M, Iijima H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:647-658

Published Date: 17 October 2018

Perspectives

Quick guide to type 2 diabetes self-management education: creating an interdisciplinary diabetes management team

Chester B, Stanely WG, Geetha T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:641-645

Published Date: 17 October 2018

To fast or not to fast during the month of Ramadan? A comprehensive survey on religious beliefs and practices among Moroccan diabetic patients

Al-Balhan E, Khabbache H, Laaziz A, Watfa A, Mhamdi A, Del Puente G, Bragazzi NL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:633-640

Published Date: 16 October 2018

Effects of Caralluma russeliana stem extract on some physiological parameters in streptozotocin-induced diabetic male rats

Zari TA, Al-Thebaiti MA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:619-631

Published Date: 12 October 2018

Plasma stearoyl-CoA desaturase activity indices and bile acid concentrations after a low-fat meal: association with a genetic variant in the FTO gene

Skuladottir GV, Oskarsdottir H, Pisanu C, Sjödin M, Lindberg J, Mwinyi J, Schiöth HB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:611-618

Published Date: 9 October 2018

Original Research

Can reducing sitting time in the university setting improve the cardiometabolic health of college students?

Butler KM, Ramos JS, Buchanan CA, Dalleck LC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:603-610

Published Date: 8 October 2018

Urinary TGF-β1 was not independently associated with renal function in diabetes mellitus

Sauriasari R, Pratiwi MY

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:597-602

Published Date: 8 October 2018

Factors associated with adherence to diabetes care recommendations among children and adolescents with type 1 diabetes: a facility-based study in two urban diabetes clinics in Uganda [Corrigendum]

Kyokunzire C, Matovu N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:595-596

Published Date: 5 October 2018

Review

Obesity management in Prader–Willi syndrome: current perspectives

Crinò A, Fintini D, Bocchini S, Grugni G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:579-593

Published Date: 4 October 2018

Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents

Han J, Tang Y, Lu M, Hua H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:565-577

Published Date: 28 September 2018

Identification of key gene pathways and coexpression networks of islets in human type 2 diabetes

Li L, Pan Z, Yang S, Shan W, Yang Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:553-563

Published Date: 28 September 2018

Developmental origins of health and disease: a new approach for the identification of adults who suffered undernutrition in early life

Ferreira HS, Xavier Junior AF, Assunção ML, Uchôa TC, Lira-Neto AB, Nakano RP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:543-551

Published Date: 26 September 2018

Obesity and nonalcoholic fatty liver disease: current perspectives

Sarwar R, Pierce N, Koppe S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:533-542

Published Date: 25 September 2018

Assessment of sleep quality and its predictors among patients with diabetes in Jazan, Saudi Arabia

Darraj A, Mahfouz MS, Alsabaani A, Sani M, Alameer A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:523-531

Published Date: 25 September 2018

Metabolic syndrome and blood pressure: are they related or not?

Jonnalagadda VG, Uppulapu SK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:521-522

Published Date: 24 September 2018

Original Research

Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians

Mahamid M, Khoury T, Amara H, Siadi M, Mohamed J, Mari A, Shalabi R, Sholy H, Nseir W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:515-519

Published Date: 24 September 2018

Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials

Albers JW, Jacobson R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:493-514

Published Date: 24 September 2018

Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice

Jarrar YB, Al-Essa L, Kilani A, Hasan M, Al-Qerem W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:483-492

Published Date: 25 September 2018

Letter

Nutrition therapy for type 2 diabetes: confirmed efficacy on individualized management

Wei FX, Qi XP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:479-481

Published Date: 13 September 2018

Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release

Hurt RT, Mundi MS, Ebbert JO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:469-478

Published Date: 4 September 2018

Efficacy of bariatric surgery in improving metabolic outcomes in patients with diabetes. A 24-month follow-up study from a single center in the UAE

Alnageeb H, Abdelgadir E, Khalifa A, Suliman M, Gautam S, Layani L, Subramaniam S, Bashier A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:459-467

Published Date: 3 September 2018

Original Research

Daily intake of Kaempferia parviflora extract decreases abdominal fat in overweight and preobese subjects: a randomized, double-blind, placebo-controlled clinical study

Yoshino S, Awa R, Miyake Y, Fukuhara I, Sato H, Ashino T, Tomita S, Kuwahara H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:447-458

Published Date: 28 August 2018

Association between polymorphisms in SLC15A1 and PLA2G16 genes and development of obesity in Chinese subjects

Wang CY, Liu S, Xie XN, Luo ZY, Yang L, Tan ZR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:439-446

Published Date: 22 August 2018

Review

Medications that cause weight gain and alternatives in Canada: a narrative review

Wharton S, Raiber L, Serodio KJ, Lee J, Christensen RAG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:427-438

Published Date: 21 August 2018

Prevalence of diabetic comorbidities and knowledge and practices of foot care among diabetic patients: a cross-sectional study

Abdulghani HM, AlRajeh AS, AlSalman BH, AlTurki LS, AlNajashi NS, Irshad M, Alharbi KH, AlBalawi YE, AlSuliman YA, Ahmad T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:417-425

Published Date: 16 August 2018

Original Research

Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka

Weerarathna TP, Herath HMM, Liyanage G, Weerarathna MK, Senadeera V

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:409-415

Published Date: 8 August 2018

Original Research

Prevalence of the metabolic syndrome according to different criteria in the male population during the Blue November Campaign in Natal, RN, Northeastern Brazil

Espósito RC, Medeiros PJ, Silva FS, Oliveira AG, Soares Aragão CF, Oliveira Rocha HA, Moreira SA, Farias Sales VS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:401-408

Published Date: 6 August 2018

Original Research

Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation

Zghoul N, Alam-Eldin N, Mak IT, Silver B, Weglicki WB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:389-400

Published Date: 2 August 2018

Original Research

Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016

Tripathy JP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:381-387

Published Date: 31 July 2018

Original Research

Effects of Spirulina platensis microalgae on antioxidant and anti-inflammatory factors in diabetic rats

Nasirian F, Dadkhah M, Moradi-kor N, Obeidavi Z

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:375-380

Published Date: 31 July 2018

Migraine in adults with diabetes; is there an association? Results of a population-based study

López-de-Andrés A, del Barrio JL, Hernández-Barrera V, de Miguel-Díez J, Jimenez-Trujillo I, Martinez-Huedo MA, Jimenez-García R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:367-374

Published Date: 20 July 2018

Original Research

Hypoglycemic activity and constituents analysis of blueberry (Vaccinium corymbosum) fruit extracts

Huang W, Yao L, He X, Wang L, Li M, Yang YX, Wan C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:357-366

Published Date: 17 July 2018

Original Research

Weight outcome after 2 years of a diet that excludes six processed foods: exploratory study of the “1,2,3 diet” in a moderately obese population

Courie R, Gaillard M, Lainas P, Hansel B, Naveau S, Dagher I, Tranchart H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:345-355

Published Date: 12 July 2018

Review

Depression in people with type 2 diabetes: current perspectives

Darwish L, Beroncal E, Sison MV, Swardfager W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:333-343

Published Date: 10 July 2018

Effects of glucosyl-hesperidin and physical training on body weight, plasma lipids, oxidative status and vascular reactivity of rats fed with high-fat diet

Tomazini Gonçalves T, Lazaro CM, De Mateo FG, Campos MCB, Mezencio JGB, Claudino MA, Carvalho PO, Webb RC, Priviero FBM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:321-332

Published Date: 4 July 2018

Original Research

Predictors of major lower limb amputation in type 2 diabetic patients referred for hospital care with diabetic foot syndrome

Shatnawi NJ, Al-Zoubi NA, Hawamdeh HM, Khader YS, Gharaibeh K, Heis HA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:313-319

Published Date: 22 June 2018

Original Research

Effect of aerobic exercise on echocardiographic epicardial adipose tissue thickness in overweight individuals

Bairapareddy KC, Maiya AG, Kumar P, Nayak K, Guddattu V, Nayak V

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:303-312

Published Date: 22 June 2018

Original Research

Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes

do Nascimento de Oliveira V, Lima-Neto, ABM, van Tilburg MF, de Oliveira Monteiro-Moreira AC, Duarte Pinto Lobo M, Rondina D, Fernandes VO, Montenegro AP, Montenegro RM Jr, Guedes MIF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:289-301

Published Date: 13 June 2018

Original Research

Chronic oscillating glucose challenges disarrange innate immune homeostasis to potentiate the variation of neutrophil–lymphocyte ratio in rats with or without hidden diabetes mellitus

Yang G, Yan R, Tong H, Zhang J, Chen B, Xue X, Wang J, Chu M, Jin S, Li M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:277-288

Published Date: 13 June 2018

Original Research

The influences of bariatric surgery on hemoglobin A1c in a sample of obese patients in Saudi Arabia

Ahmed AE, Alanazi WR, Ahmed RA, AlJohi W, AlBuraikan DA, AlRasheed BA, ALMuqbil BI, Al-Zahrani AA, Yousef ZM, AL-Jahdali H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:271-276

Published Date: 12 June 2018

Review

Success of nutrition-therapy interventions in persons with type 2 diabetes: challenges and future directions

Franz MJ, MacLeod J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:265-270

Published Date: 11 June 2018

Review

Autoamputation of diabetic toe with dry gangrene: a myth or a fact?

Al Wahbi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:255-264

Published Date: 1 June 2018

Original Research

Performance of body mass index and percentage of body fat in predicting cardiometabolic risk factors in Thai adults

Vanavanan S, Srisawasdi P, Rochanawutanon M, Kumproa N, Kruthkul K, Kroll MH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:241-253

Published Date: 1 June 2018

Original Research

Relative handgrip strength as a marker of metabolic syndrome: the Korea National Health and Nutrition Examination Survey (KNHANES) VI (2014–2015)

Yi DW, Khang AR, Lee HW, Son SM, Kang YH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:227-240

Published Date: 23 May 2018

Original Research

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach

Pollock RF, Chubb B, Valentine WJ, Heller S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:217-226

Published Date: 16 May 2018

Original Research

Severity of primary open-angle glaucoma in patients with hypertension and diabetes

Khatri A, Shrestha JK, Thapa M, Khatri BK, Kharel M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:209-215

Published Date: 16 May 2018

Original Research

Influence of FTO rs9939609 polymorphism on appetite, ghrelin, leptin, IL6, TNFα levels, and food intake of women with morbid obesity

Magno FCCM, Guaraná HC, Fonseca ACP, Cabello GMK, Carneiro JRI, Pedrosa AP, Ximenes AC, Rosado EL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:199-207

Published Date: 14 May 2018

Review

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data

Kugler AJ, Thiman ML

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:187-197

Published Date: 9 May 2018

Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent

Yan LJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:183-186

Published Date: 4 May 2018

Original Research

Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women

Fatani SH, Abdelbasit NA, Al-Amodi HS, Mukhtar MM, Babakr AT

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:175-181

Published Date: 1 May 2018

Review

Adjunctive therapy for glucose control in patients with type 1 diabetes

Harris K, Boland C, Meade L, Battise D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:159-173

Published Date: 27 April 2018

Original Research

Plasma concentrations of zonulin are elevated in obese men with fatty liver disease

Kim AS, Ko HJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:149-157

Published Date: 23 April 2018

Review

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors

Santos Cavaiola T, Pettus J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:133-148

Published Date: 12 April 2018

Letter

Statin on insulin and adiponectin levels: true or false prophecy?

Jonnalagadda VG, Shaik A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:131-132

Published Date: 12 April 2018

Letter

Subcutaneous to visceral fat ratio: a possible risk factor for metabolic syndrome and cardiovascular diseases

Shafqat MN, Haider M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:129-130

Published Date: 12 April 2018

Original Research

Effect of dietary oils on peripheral neuropathy-related endpoints in dietary obese rats

Coppey L, Davidson E, Shevalye H, Torres ME, Yorek MA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:117-127

Published Date: 9 April 2018

Original Research

Screening and management of gestational diabetes in Mexico: results from a survey of multilocation, multi-health care institution practitioners

Dainelli L, Prieto-Patron A, Silva-Zolezzi I, Sosa-Rubi SG, Espino y Sosa S, Reyes-Muñoz E, Lopez-Ridaura R, Detzel P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:105-116

Published Date: 5 April 2018

Original Research

Factors associated with adherence to diabetes care recommendations among children and adolescents with type 1 diabetes: a facility-based study in two urban diabetes clinics in Uganda

Kyokunzire C, Matovu N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:93-104

Published Date: 29 March 2018

Original Research

Trace elements and oxidative stress in children with type 1 diabetes mellitus

Alghobashy AA, Alkholy UM, Talat MA, Abdalmonem N, Zaki A, Ahmed IA, Mohamed RH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:85-92

Published Date: 26 March 2018

Original Research

Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases

Singh R, Pervin S, Lee S, Kuo A, Grijalva V, David J, Vergnes L, Reddy ST

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:65-84

Published Date: 26 March 2018

Original Research

The impact of carbohydrate intake and its sources on hemoglobin A1c levels in Japanese patients with type 2 diabetes not taking anti-diabetic medication

Haimoto H, Watanabe S, Komeda M, Wakai K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:53-64

Published Date: 9 March 2018

Review

Protein-induced satiation and the calcium-sensing receptor

Ojha U

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:45-51

Published Date: 9 March 2018

Original Research

Decreased health-related quality of life in patients with diabetic foot problems

Sothornwit J, Srisawasdi G, Suwannakin A, Sriwijitkamol A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:35-43

Published Date: 7 March 2018

Original Research

Randomized trial of amino acid mixture combined with physical activity promotion for abdominal fat reduction in overweight adults

Ueda K, Sasai H, Tsujimoto T, Sanbongi C, Ikegami S, Kobayashi H, Shioya N, Suzuki S, Nakata Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:23-33

Published Date: 26 February 2018

Original Research

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia

Alzaheb RA, Altemani AH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:15-21

Published Date: 31 January 2018

Perspectives

Linking care of patients with obesity to outpatient weight control clinics following acute hospitalizations

Harris CM, Cheskin LJ, Gipson-Jones TL, Hartfield JA, Kisuule F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:11-14

Published Date: 24 January 2018

Original Research

Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences

DiBonaventura MD, Meincke H, Le Lay A, Fournier J, Bakker E, Ehrenreich A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:1-10

Published Date: 22 December 2017

Review

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience

Chan WB, Chen JF, Goh SY, Vu TTH, Isip-Tan IT, Mudjanarko SW, Bajpai S, Mabunay MA, Bunnag P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:521-532

Published Date: 15 December 2017

Effects of a proposed physical activity and diet control to manage constipation in middle-aged obese women

Tantawy SA, Kamel DM, Abdelbasset WK, Elgohary HM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:513-519

Published Date: 14 December 2017

Original Research

Visceral-to-subcutaneous fat ratio as a predictor of the multiple metabolic risk factors for subjects with normal waist circumference in Korea

Oh YH, Moon JH, Kim HJ, Kong MH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:505-511

Published Date: 11 December 2017

Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans

Wu SH, McCormick JB, Curran JE, Fisher-Hoch SP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:491-503

Published Date: 6 December 2017

Original Research

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction

Gruzdeva O, Uchasova E, Dyleva Y, Akbasheva O, Karetnikova V, Shilov A, Barbarash O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:481-489

Published Date: 5 December 2017

Obesity and brain illness: from cognitive and psychological evidences to obesity paradox

Monda V, La Marra M, Perrella R, Caviglia G, Iavarone A, Chieffi S, Messina G, Carotenuto M, Monda M, Messina A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:473-479

Published Date: 21 November 2017

Obesity and morbid obesity associated with higher odds of hypoalbuminemia in adults without liver disease or renal failure

Mosli RH, Mosli HH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:467-472

Published Date: 8 November 2017

Original Research

Association between metabolic syndrome and sensorineural hearing loss: a cross-sectional study of 11,114 participants

Aghazadeh-Attari J, Mansorian B, Mirza-Aghazadeh-Attari M, Ahmadzadeh J, Mohebbi I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:459-465

Published Date: 6 November 2017

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]

Irons BK, Minze MG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:457-458

Published Date: 31 October 2017

Original Research

Online continuing medical education as a key link for successful noncommunicable disease self-management: the CASALUD™ Model

Gallardo-Rincón H, Saucedo-Martínez R, Mujica-Rosales R, Lee EM, Israel A, Torres-Beltran B, Quijano-González Ú, Atkinson ER, Kuri-Morales P, Tapia-Conyer R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:443-455

Published Date: 16 October 2017

Original Research

Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan

Bakkar MM, Haddad MF, Gammoh YS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:435-441

Published Date: 11 October 2017

Review

Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives

Fisher VL, Tahrani AA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:419-434

Published Date: 6 October 2017

Commentary

Weight loss medications in Canada – a new frontier or a repeat of past mistakes?

Wharton S, Lee J, Christensen RAG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:413-417

Published Date: 4 October 2017

Original Research

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes

Sikirica MV, Martin AA, Wood R, Leith A, Piercy J, Higgins V

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:403-412

Published Date: 29 September 2017

Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy

Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:393-402

Published Date: 20 September 2017

Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points

Braz MAD, Vieira JN, Gomes FO, Silva PR, Santos OTM, Rocha IMGD, Sousa IMD, Fayh APT

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:385-391

Published Date: 12 September 2017

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:375-383

Published Date: 13 September 2017

Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study

Le NTD, Dinh Pham L, Quang Vo T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:363-374

Published Date: 29 August 2017

Review

Novel biomarkers for prediabetes, diabetes, and associated complications

Dorcely B, Katz K, Jagannathan R, Chiang SS, Oluwadare B, Goldberg IJ, Bergman M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:345-361

Published Date: 14 August 2017

Review

Diabetes and dyslipidemia: characterizing lipoprotein metabolism

Tomkin GH, Owens D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:333-343

Published Date: 28 July 2017

Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin

Yu H, Woo VC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:317-332

Published Date: 21 July 2017

Review

The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy

Kumar N, Sullivan S, Thompson CC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:311-316

Published Date: 6 July 2017

Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults

Sasai H, Ueda K, Tsujimoto T, Kobayashi H, Sanbongi C, Ikegami S, Nakata Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:297-309

Published Date: 6 July 2017

Review

Prevalence of diabetes and obesity in association with prematurity and growth restriction

Kopec G, Shekhawat PS, Mhanna MJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:285-295

Published Date: 6 July 2017

Review

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus

Lau IT, Lee KF, So WY, Tan K, Yeung VTF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:273-284

Published Date: 30 June 2017

Original Research

Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region

Bekele S, Yohannes T, Mohammed AE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:265-271

Published Date: 22 June 2017

Diabetes in sub-Saharan Africa – from policy to practice to progress: targeting the existing gaps for future care for diabetes

Pastakia SD, Pekny CR, Manyara SM, Fischer L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:247-263

Published Date: 22 June 2017

Original Research

Effects of a tailored lifestyle self-management intervention (TALENT) study on weight reduction: a randomized controlled trial

Melchart D, Löw P, Wühr E, Kehl V, Weidenhammer W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:235-245

Published Date: 19 June 2017

Review

Off-label drugs for weight management

Hendricks EJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:223-234

Published Date: 10 June 2017

Original Research

Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway

Civantos E, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O, Mas S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:207-222

Published Date: 7 June 2017

Expert Opinion

Personalized multistep cognitive behavioral therapy for obesity

Dalle Grave R, Sartirana M, El Ghoch M, Calugi S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:195-206

Published Date: 1 June 2017

Clinical Trial Report

Changes in muscle strength after diet-induced weight reduction in adult men with obesity: a prospective study

Kim B, Tsujimoto T, So R, Zhao X, Oh S, Tanaka K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:187-194

Published Date: 9 May 2017

Original Research

Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study

Mendivil CO, Toloza FJK, Ricardo-Silgado ML, Morales-Álvarez MC, Mantilla-Rivas JO, Pinzón-Cortés JA, Lemus HN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:179-185

Published Date: 8 May 2017

Original Research

Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis

Suksomboon N, Poolsup N, Darli Ko Ko H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:169-177

Published Date: 2 May 2017

Review

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus

Ahmadieh H, Ghazal N, Azar ST

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:161-167

Published Date: 2 May 2017

Original Research

Hearing thresholds in adult Nigerians with diabetes mellitus: a case–control study

Nwosu JN, Chime EN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:155-160

Published Date: 2 May 2017

Short Report

Do we need to measure vitamin B12 and magnesium in morbidly obese patients with type 2 diabetes mellitus?

Wåhlén A, Haenni A, Johansson HE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:151-154

Published Date: 2 May 2017

Original Research

Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya

Otieno CFF, Kanu JE, Karari EM, Okech-Helu V, Joshi MD, Mutai K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:141-149

Published Date: 28 April 2017

Review

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

Levin PA, Nguyen H, Wittbrodt ET, Kim SC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:123-139

Published Date: 4 April 2017

Original Research

Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials

Orme ME, Nguyen H, Lu JY, Thomas SA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:111-122

Published Date: 29 March 2017

Review

Early-life chemical exposures and risk of metabolic syndrome

De Long NE, Holloway AC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:101-109

Published Date: 21 March 2017

Original Research

The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin

Gerlanc NM, Cai J, Tkacz J, Bolge SC, Brady BL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:89-99

Published Date: 20 March 2017

Review

Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists

Courtney H, Nayar R, Rajeswaran C, Jandhyala R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:79-87

Published Date: 13 March 2017

Review

Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations

Tatum JA, Meneveau MO, Brayman KL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:73-78

Published Date: 28 February 2017

Review

Clinical utility of metabolic syndrome severity scores: considerations for practitioners

DeBoer MD, Gurka MJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:65-72

Published Date: 20 February 2017

Original Research

Association between obesity and heart rate variability indices: an intuition toward cardiac autonomic alteration – a risk of CVD

Yadav RL, Yadav PK, Yadav LK, Agrawal K, Sah SK, Islam MN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:57-64

Published Date: 17 February 2017

Original Research

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:47-55

Published Date: 27 January 2017

Original Research

Different consecutive training protocols to design an intervention program for overweight youth: a controlled study

Fiorilli G, Iuliano E, Aquino G, Campanella E, Tsopani D, Di Costanzo A, Calcagno G, di Cagno A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:37-45

Published Date: 16 January 2017

Original Research

The effects of exercise training and caloric restriction on the cardiac oxytocin natriuretic peptide system in the diabetic mouse

Broderick TL, Jankowski M, Gutkowska J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:27-36

Published Date: 11 January 2017

Original Research

Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity

Karimian S, Stein J, Bauer B, Teupe C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:19-25

Published Date: 7 January 2017

Original Research

Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation

Lamos EM, Wijesinha MA, Ramhamdani S, Magder LS, Silver KD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:13-17

Published Date: 5 January 2017

Review

Coaching and barriers to weight loss: an integrative review

Muñoz Obino KF, Aguiar Pereira C, Caron-Lienert RS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:1-11

Published Date: 23 December 2016

Original Research

Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients

Cadegiani FA, Silva OS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:443-446

Published Date: 7 December 2016

Review

rDNA insulin glargine U300 – a critical appraisal

Wang F, Zassman S, Goldberg PA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:425-441

Published Date: 2 December 2016

Original Research

Evaluation of serum ferritin and some metal elements in type 2 diabetes mellitus patients: comparative cross-sectional study

Wolide AD, Zawdie B, Alemayehu T, Tadesse S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:417-424

Published Date: 2 December 2016

Original Research

Symptom profiles of subsyndromal depression in disease clusters of diabetes, excess weight, and progressive cerebrovascular conditions: a promising new type of finding from a reliable innovation to estimate exhaustively specified multiple indicators–multiple causes (MIMIC) models

Francoeur RB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:391-416

Published Date: 8 December 2016

Review

eHealth technologies to support nutrition and physical activity behaviors in diabetes self-management

Rollo ME, Aguiar EJ, Williams RL, Wynne K, Kriss M, Callister R, Collins CE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:381-390

Published Date: 4 November 2016

Original Research

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015

Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:371-380

Published Date: 1 November 2016

Review

Practical combination therapy based on pathophysiology of type 2 diabetes

Levin PA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:355-369

Published Date: 31 October 2016

Original Research

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

Ghosh S, Trivedi S, Sanyal D, Modi KD, Kharb S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:347-353

Published Date: 8 November 2016

Original Research

Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study

Scheerer MF, Rist R, Proske O, Meng A, Kostev K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:337-345

Published Date: 31 October 2016

Original Research

Myocutaneous revascularization following graded ischemia in lean and obese mice

Clark RM, Coffman B, McGuire PG, Howdieshell TR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:325-336

Published Date: 30 September 2016

Original Research

Exercise portrayal in children’s television programs: analysis of the UK and Irish programming

Scully P, Reid O, Macken AP, Healy M, Saunders J, Leddin D, Cullen W, Dunne CP, O’Gorman CS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:317-324

Published Date: 23 September 2016

Review

Management of pancreatogenic diabetes: challenges and solutions

Makuc J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:311-315

Published Date: 25 August 2016

Review

Role of sleep quality in the metabolic syndrome

Koren D, Dumin M, Gozal D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:281-310

Published Date: 25 August 2016

Original Research

Prevalence and determinants of metabolic syndrome: a cross-sectional survey of general medical outpatient clinics using National Cholesterol Education Program-Adult Treatment Panel III criteria in Botswana

Omech B, Tshikuka JG, Mwita JC, Tsima B, Nkomazana O, Amone-P'Olak K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:273-279

Published Date: 30 August 2016

Original Research

Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats

Suman RK, Mohanty IR, Maheshwari U, Borde MK, Deshmukh YA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:261-272

Published Date: 29 August 2016

Review

Teneligliptin in management of type 2 diabetes mellitus

Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:251-260

Published Date: 16 August 2016

Clinical Trial Report

Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study

Ji L, Min KW, Oliveira J, Lew T, Duan R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:243-249

Published Date: 9 August 2016

Original Research

Incremental increases in economic burden parallels cardiometabolic risk factors in the US

McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:233-241

Published Date: 2 August 2016

Original Research

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

Hassoun AAK, Pathan MF, Medlej RC, Alarouj M, Shaltout I, Chawla MS, Knap D, Vaz JA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:225-232

Published Date: 26 July 2016

Original Research

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study

Saunders WB, Nguyen H, Kalsekar I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:217-223

Published Date: 15 July 2016

Commentary

Smartphone applications to aid weight loss and management: current perspectives

Sutton EF, Redman LM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:213-216

Published Date: 18 July 2016

Original Research

The relationship between the presence of lower urinary tract symptoms and waist circumference

Oliveira MC, Varella LR, Angelo PH, Micussi MT

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:207-211

Published Date: 11 July 2016

Original Research

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany

Qiao Q, Ouwens MJNM, Grandy S, Johnsson K, Kostev K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:201-205

Published Date: 28 June 2016

Original Research

Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque

Powell DR, Gay JP, Smith M, Wilganowski N, Harris A, Holland A, Reyes M, Kirkham L, Kirkpatrick LL, Zambrowicz B, Hansen G, Platt KA, van Sligtenhorst I, Ding ZM, Desai U

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:185-199

Published Date: 22 June 2016

Original Research

Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome

Walden P, Jiang Q, Jackson EA, Oral EA, Weintraub MS, Rubenfire M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:177-184

Published Date: 1 June 2016

Original Research

A qualitative study of perceptions of determinants of disease burden among young patients with type 1 diabetes and their parents in South India

Verloo H, Meenakumari M, Abraham EJ, Malarvizhi G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:169-176

Published Date: 19 May 2016

Original Research

An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method

Martin AA, Parks D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:163-168

Published Date: 19 May 2016

Original Research

Depression in diabetic patients attending University of Gondar Hospital Diabetic Clinic, Northwest Ethiopia

Birhanu AM, Alemu FM, Ashenafie TD, Balcha SA, Dachew BA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:155-162

Published Date: 11 May 2016

Review

Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications

Wu J, Jin Z, Zheng H, Yan LJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:145-153

Published Date: 10 May 2016

Original Research

Metabolic syndrome and C-reactive protein in bank employees

Cattafesta M, Bissoli NS, Salaroli LB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:137-144

Published Date: 10 May 2016

Review

Advances in the treatment of type 2 diabetes: impact of dulaglutide

Thompson AM, Trujillo JM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:125-136

Published Date: 4 May 2016

Original Research

Level of control among patients with type 2 diabetes mellitus attending diabetic clinic under family medicine compared to diabetic clinic under endocrinology

AlHabdan MA, AlAteeq MA, AlJurbou FI

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:119-124

Published Date: 18 April 2016

Review

Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus

Tajuddin N, Shaikh A, Hassan A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:109-118

Published Date: 19 April 2016

Original Research

Lifestyle Intervention for Weight Loss: a group-based program for Emiratis in Ajman, United Arab Emirates

Sadiya A, Abdi S, Abusnana S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:101-108

Published Date: 18 March 2016

Original Research

Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia

Biadgo B, Melku M, Abebe SM, Abebe M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:91-99

Published Date: 17 March 2016

Review

Childhood obesity: prevention is better than cure

Pandita A, Sharma D, Pandita D, Pawar S, Tariq M, Kaul A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:83-89

Published Date: 15 March 2016

Review

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Schwartz SS, Katz A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:71-82

Published Date: 15 March 2016

Original Research

Genistein treatment increases bone mass in obese, hyperglycemic mice

Michelin RM, Al-Nakkash L, Broderick TL, Plochocki JH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:63-70

Published Date: 15 March 2016

Original Research

Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial

Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:55-62

Published Date: 14 March 2016

Original Research

Metabolic syndrome and associated factors among outpatients of Jimma University Teaching Hospital

Abda E, Hamza L, Tessema F, Cheneke W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:47-53

Published Date: 4 March 2016

Review

Long-term weight loss maintenance for obesity: a multidisciplinary approach

Montesi L, El Ghoch M, Brodosi L, Calugi S, Marchesini G, Dalle Grave R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:37-46

Published Date: 26 February 2016

Review

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR

Kuecker CM, Vivian EM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:25-35

Published Date: 23 February 2016

Original Research

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care

Pscherer S, Kostev K, Dippel FW, Rathmann W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:17-23

Published Date: 19 February 2016

Original Research

Assessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain

Al-Haddad FA, Rajab MH, Al-Qallaf SM, Musaiger AO, Hart KH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:11-16

Published Date: 25 January 2016

Original Research

A local renal renin–angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats

Tojo A, Kinugasa S, Fujita T, Wilcox CS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:1-10

Published Date: 18 January 2016

Review

Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant

Cebeci Z, Kir N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:555-566

Published Date: 16 November 2015

Review

SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin

Seufert J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:543-554

Published Date: 9 November 2015

Original Research

Relationship between chronic complications, hypertension, and health-related quality of life in Portuguese patients with type 2 diabetes

Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:535-542

Published Date: 30 October 2015

Original Research

Red cell distribution width in type 2 diabetic patients

Nada AM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:525-533

Published Date: 30 October 2015

Original Research

Specific cut-off points for waist circumference and waist-to-height ratio as predictors of cardiometabolic risk in Black subjects: a cross-sectional study in Benin and Haiti

EL Mabchour A, Delisle H, Vilgrain C, Larco P, Sodjinou R, Batal M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:513-523

Published Date: 23 October 2015

Review

Emerging utility of once-weekly exenatide in patients with type 2 diabetes

Goud A, Zhong J, Rajagopalan S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:505-512

Published Date: 21 October 2015

Original Research

Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks

Nikokavoura EA, Johnston KL, Broom J, Wrieden WL, Rolland C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:495-503

Published Date: 14 October 2015

Review

Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes

Thuillier P, Alavi Z, Kerlan V

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:483-493

Published Date: 1 October 2015

Review

The clinical utility of aflibercept for diabetic macular edema

Stewart MW

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:473-482

Published Date: 18 September 2015

Original Research

Bariatric surgery outcomes: a single-center study in the United Arab Emirates

Abusnana S, Abdi S, Tagure B, Elbagir M, Maleckas A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:461-471

Published Date: 18 September 2015

Letter

Causes and consequences of obesity: epigenetics or hypokinesis?

Graham MR, Baker JS, Davies B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:455-460

Published Date: 16 September 2015

Original Research

An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting

Courtney MR, Moler EJ, Osborne JA, Whitney G, Conard SE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:447-453

Published Date: 18 September 2015

Original Research

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine

Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:437-445

Published Date: 15 September 2015

Original Research

C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese

Dongway AC, Faggad AS, Zaki HY, Abdalla BE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:427-435

Published Date: 4 September 2015

Review

Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management

Palimeri S, Palioura E, Diamanti-Kandarakis E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:415-426

Published Date: 1 September 2015

Original Research

Evaluation of the relationship between the pelvic floor muscles and insulin resistance

Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:409-413

Published Date: 28 August 2015

Original Research

Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice

Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, Pesquero JB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:399-407

Published Date: 26 August 2015

Original Research

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets

Yang C, Loehn M, Jurczyk A, Przewozniak N, Leehy L, Herrera PL, Shultz LD, Greiner DL, Harlan DM, Bortell R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:387-398

Published Date: 20 August 2015

Review

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

Gurung T, Shyangdan DS, O’Hare JP, Waugh N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:363-386

Published Date: 10 August 2015

Hypothesis

Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor

Zheng X, Li S, Zhang WH, Yang H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:357-361

Published Date: 5 August 2015

Original Research

Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice

Mashitah MW, Azizah N, Samsu N, Indra MR, Bilal M, Yunisa MV, Arisanti AD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:347-355

Published Date: 4 August 2015

Original Research

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus

Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:339-345

Published Date: 27 July 2015

Original Research

The humanistic and economic burden associated with increasing body mass index in the EU5

Gupta S, Richard L, Forsythe A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:327-338

Published Date: 22 July 2015

Review

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements

Yang F, Stewart M, Ye J, DeMets D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:315-325

Published Date: 20 July 2015

Original Research

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study

Penfornis A, Fiquet B, Blicklé JF, Dejager S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:303-313

Published Date: 3 July 2015

Review

Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome

Smith CJ, Ryckman KK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:295-302

Published Date: 29 June 2015

Review

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination

Fleming JW, Fleming LW, Davis CS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:287-294

Published Date: 25 June 2015

Original Research

Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose

Evans M, Judy WV, Wilson D, Rumberger JA, Guthrie N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:275-286

Published Date: 25 June 2015

Review

Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions

McGrice M, Don Paul K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:263-274

Published Date: 23 June 2015

Review

Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?

Raffaelli M, Sessa L, Mingrone G, Bellantone R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:255-262

Published Date: 8 June 2015

Original Research

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients

MacConell L, Gurney K, Malloy J, Zhou M, Kolterman O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:241-253

Published Date: 18 May 2015

Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism

Fu L, Li F, Bruckbauer A, Cao Q, Cui X, Wu R, Shi H, Xue B, Zemel MB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:227-239

Published Date: 6 May 2015

Original Research

Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital

Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:219-226

Published Date: 29 April 2015

Original Research

Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study

Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:213-218

Published Date: 23 April 2015

Review

Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients

Aziz KMA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:207-211

Published Date: 16 April 2015

Original Research

Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia

Mohammed AE, Shenkute TY, Gebisa WC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:197-206

Published Date: 15 April 2015

Review

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence

Sosale A, Saboo B, Sosale B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:189-196

Published Date: 15 April 2015

Review

Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity

Wu J, Yan LJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:181-188

Published Date: 2 April 2015

Original Research

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey

Petrella RJ, Gill DP, Berrou JP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:173-180

Published Date: 24 March 2015

Review

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability

Nishio S, Abe M, Ito H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:163-171

Published Date: 18 March 2015

Original Research

Factors affecting high-sensitivity cardiac troponin T elevation in Japanese metabolic syndrome patients

Hitsumoto T, Shirai K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:157-162

Published Date: 10 March 2015

Original Research

Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial

Nagatomo A, Nishida N, Fukuhara I, Noro A, Kozai Y, Sato H, Matsuura Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:147-156

Published Date: 6 March 2015

Original Research

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, Vannasaeng S, Thongtang N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:137-145

Published Date: 2 March 2015

Review

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management

Nitzan O, Elias M, Chazan B, Saliba W,

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:129-136

Published Date: 26 February 2015

Original Research

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:121-127

Published Date: 26 February 2015

Original Research

Effect of different exercise intensities on the pancreas of animals with metabolic syndrome

Amaral F, Lima NEA, Ornelas E, Simardi L, Fonseca FLA, Maifrino LBM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:115-120

Published Date: 13 February 2015

Original Research

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation

Tojo A, Hatakeyama S, Kinugasa S, Nangaku M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:103-113

Published Date: 13 February 2015

Original Research

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus

Mazzilli R, Imbrogno N, Elia J, Delfino M, Bitterman O, Napoli A, Mazzilli F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:97-101

Published Date: 11 February 2015

Original Research

Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins

Di Pierro F, Bellone I, Rapacioli G, Putignano P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:89-96

Published Date: 4 February 2015

Review

GABAergic system in the endocrine pancreas: a new target for diabetes treatment

Wan Y, Wang Q, Prud’homme GJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:79-87

Published Date: 3 February 2015

Original Research

The prevalence of adverse cardiometabolic responses to exercise training with evidence-based practice is low

Dalleck LC, Van Guilder GP, Richardson TB, Vella CA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:73-78

Published Date: 29 January 2015

Original Research

Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study

Abebe SM, Berhane Y, Worku A, Alemu S, Mesfin N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:65-71

Published Date: 27 January 2015

Original Research

Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study

Steylen PMJ, van der Heijden FMMA, Hoogendijk WJG, Verhoeven WMA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:57-63

Published Date: 23 January 2015

Review

Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment

Kruger DF, LaRue S, Estepa P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:49-56

Published Date: 16 January 2015

Short Report

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis

Kostev K, Dippel FW, Rathmann W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:45-48

Published Date: 14 January 2015

Review

Psychosocial interventions for the diabetic patient

Harvey JN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:29-43

Published Date: 9 January 2015

Review

Type 2 diabetes in Brazil: epidemiology and management

Almeida-Pititto B, Dias ML, Moraes ACF, Ferreira SRG, Franco DR, Eliaschewitz FG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:17-28

Published Date: 5 January 2015

Original Research

Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children

Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:9-15

Published Date: 17 December 2014

Original Research

Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics

Takahashi PY, St Sauver JL, Finney Rutten LJ, Jacobson RM, Jacobson DJ, McGree ME, Ebbert JO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:1-8

Published Date: 16 December 2014

Review

Mechanism linking diabetes mellitus and obesity

Al-Goblan AS, Al-Alfi MA, Khan MZ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:587-591

Published Date: 4 December 2014

Review

Genetic and epigenetic catalysts in early-life programming of adult cardiometabolic disorders

Estampador AC, Franks PW

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:575-586

Published Date: 1 December 2014

Letter

Management of adult diabetic ketoacidosis

Rosival V

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:571-573

Published Date: 28 November 2014

Original Research

Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria

Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Mene-Afejuku TO, Adeyeye VO, Bamikole OJ, Bisiriyu LA, Ajayi OE, Ogunyemi SA, Oketona OA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:565-570

Published Date: 26 November 2014

Original Research

Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep

Duckett SK, Volpi-Lagreca G, Alende M, Long NM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:553-563

Published Date: 20 November 2014

Original Research

Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus

Shmendi A, Pirie F, Naidoo DP, Tlou B, Pilloy W, Motala AA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:545-552

Published Date: 14 November 2014

Perspectives

Integrated bariatric surgery residency

Eltorai AE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:543-544

Published Date: 13 November 2014

Original Research

Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals

Wang X, DuBois DC, Sukumaran S, Ayyar V, Jusko WJ, Almon RR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:531-541

Published Date: 11 November 2014

Review

Independent and combined effect of diet and exercise in adults with prediabetes

Sénéchal M, Slaght J, Bharti N, Bouchard DR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:521-529

Published Date: 31 October 2014

Original Research

Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations

Babakr AT, Elsheikh OM, Almarzouki AA, Assiri AM, Abdalla BE, Zaki HY, Fatani SH, NourEldin EM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:513-520

Published Date: 24 October 2014

Original Research

Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents

Boodai SA, Cherry LM, Sattar NA, Reilly JJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:505-511

Published Date: 24 October 2014

Original Research

Expression of gluconeogenic enzymes and 11β-hydroxysteroid dehydrogenase type 1 in liver of diabetic mice after acute exercise

Brust KB, Corbell KA, Al-Nakkash L, Babu JR, Broderick TL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:495-504

Published Date: 21 October 2014

Review

Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience

Juarez DT, Demaris KM, Goo R, Mnatzaganian CL, Wong Smith H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:487-494

Published Date: 20 October 2014

Review

Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications

Beatrice AM, Dutta D, Kumar M, Shivaprasad KS, Sinha A, Ray S, Chowdhury S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:481-486

Published Date: 20 October 2014

Original Research

Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus

MacPhail M, Mullan B, Sharpe L, MacCann C, Todd J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:469-479

Published Date: 16 October 2014

Retraction

Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects [Retraction]

Vinson JA, Burnham BR, Nagendran MV

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:467-468

Published Date: 16 October 2014

Original Research

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland

Huber CA, Diem P, Schwenkglenks M, Rapold R, Reich O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:455-465

Published Date: 1 October 2014

Original Research

Effect of BMI on cardiovascular and metabolic syndrome risk factors in an Appalachian pediatric population

Weber KE, Fischl AFR, Murray PJ, Conway BN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:445-453

Published Date: 25 September 2014

Original Research

The effect of a lifestyle intervention on metabolic health in young women

Dunn SL, Siu W, Freund J, Boutcher SH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:437-444

Published Date: 19 September 2014

Review

Relationship between chronic kidney disease and metabolic syndrome: current perspectives

Nashar K, Egan BM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:421-435

Published Date: 18 September 2014

Review

Sex differences in type 2 diabetes: focus on disease course and outcomes

Arnetz L, Ekberg NR, Alvarsson M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:409-420

Published Date: 16 September 2014

Original Research

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

Hernández-Ojeda J, Román-Pintos LM, Rodríguez-Carrízalez AD, Troyo-Sanromán R, Cardona-Muñoz EG, Alatorre-Carranza MP, Miranda-Díaz AG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:401-407

Published Date: 4 September 2014

Review

Treating the elderly diabetic patient: special considerations

Kezerle L, Shalev L, Barski L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:391-400

Published Date: 28 August 2014

Original Research

Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment

Wang X, DuBois DC, Cao Y, Jusko WJ, Almon RR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:381-389

Published Date: 1 August 2014

Original Research

A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype

Dalleck LC, Van Guilder GP, Richardson TB, Bredle DL, Janot JM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:369-380

Published Date: 1 August 2014

Review

Is adherence a relevant issue in the self-management education of diabetes? A mixed narrative review

Debussche X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:357-367

Published Date: 29 July 2014

Review

Elevated body mass index as a risk factor for chronic kidney disease: current perspectives

Garland JS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:347-355

Published Date: 29 July 2014

Original Research

Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco

El Brini O, Akhouayri O, Gamal A, Mesfioui A, Benazzouz B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:341-346

Published Date: 31 July 2014

Review

Linking obesity with type 2 diabetes: the role of T-bet

Wali JA, Thomas HE, Sutherland APR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:331-340

Published Date: 22 July 2014

Original Research

Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice

Leung L, Kang J, Rayyan E, Bhakta A, Barrett B, Larsen D, Jelinek R, Willey J, Cochran S, Broderick TL, Al-Nakkash L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:321-330

Published Date: 21 July 2014

Original Research

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin

Ohira M, Yamaguchi T, Saiki A, Ban N, Kawana H, Nagumo A, Murano T, Shirai K, Tatsuno I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:313-319

Published Date: 17 July 2014

Original Research

The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects

Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:305-312

Published Date: 11 July 2014

Original Research

Relationship between insulin resistance and plasma vitamin D in adults

Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:297-303

Published Date: 7 July 2014

Original Research

Abdominal obesity: causal factor or simply a symptom of obesity-related health risk

Oh S, Tanaka K, Noh JW, So R, Tsujimoto T, Sasai H, Kim M, Shoda J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:289-296

Published Date: 3 July 2014

Review

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus

Holland DQ, Neumiller JJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:277-288

Published Date: 3 July 2014

Original Research

Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet

Vickers SP, Cheetham SC, Headland KR, Dickinson K, Grempler R, Mayoux E, Mark M, Klein T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:265-275

Published Date: 1 July 2014

Review

Management of adult diabetic ketoacidosis

Gosmanov AR, Gosmanova EO, Dillard-Cannon E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:255-264

Published Date: 30 June 2014

Review

AMPK activation: a therapeutic target for type 2 diabetes?

Coughlan KA, Valentine RJ, Ruderman NB, Saha AK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:241-253

Published Date: 24 June 2014

Review

Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes

Mann KV, Raskin P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:229-239

Published Date: 24 June 2014

Case Series

Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India

Sinha B, Gangopadhyay KK, Ghosal S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:225-228

Published Date: 23 June 2014

Review

Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges

Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:211-223

Published Date: 23 June 2014

Original Research

Metabolic profiling of plasma amino acids shows that histidine increases following the consumption of pork

Samman S, Crossett B, Somers M, Bell KJ, Lai NT, Sullivan DR, Petocz P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:203-210

Published Date: 19 June 2014

Original Research

Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance

Maekawa S, Kawahara T, Nomura R, Murase T, Ann Y, Oeholm M, Harada M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:195-201

Published Date: 13 June 2014

Original Research

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose

Das SS, Hayashi H, Sato T, Yamada R, Hiratsuka M, Hirasawa N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:185-194

Published Date: 24 May 2014

Review

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus

Lorber D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:169-183

Published Date: 23 May 2014

Review

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting

Ofori SN, Unachukwu CN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:159-168

Published Date: 23 May 2014

Original Research

Prevalence and pattern of overweight and obesity in three rural communities in southwest Nigeria

Adebayo RA, Balogun MO, Adedoyin RA, Obashoro-John OA, Bisiriyu LA, Abiodun OO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:153-158

Published Date: 10 May 2014

Original Research

Effects of body mass index-related disorders on cognition: preliminary results

Yesavage JA, Kinoshita LM, Noda A, Lazzeroni LC, Fairchild JK, Taylor J, Kulick D, Friedman L, Cheng J, Zeitzer JM, O'Hara R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:145-151

Published Date: 8 May 2014

Original Research

Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq

Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Mosbeh KA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:139-144

Published Date: 2 May 2014

Review

Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature

Tran NL, Barraj LM, Heilman JM, Scrafford CG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:121-137

Published Date: 24 March 2014

Review

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes

Rigato M, Fadini GP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:107-120

Published Date: 18 March 2014

Review

Diabetes and sexual dysfunction: current perspectives

Maiorino MI, Bellastella G, Esposito K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:95-105

Published Date: 6 March 2014

Review

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia

Anderson M, Powell J, Campbell KM, Taylor JR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:85-94

Published Date: 6 March 2014

Review

Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity

Joharapurkar AA, Dhanesha NA, Jain MR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:73-84

Published Date: 28 February 2014

Review

Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization

Franz MJ, Boucher JL, Evert AB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:65-72

Published Date: 24 February 2014

Review

Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes

Mackenzie RWA, Elliott BT

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:55-64

Published Date: 13 February 2014

Review

Partnering with diabetes educators to improve patient outcomes

Burke SD, Sherr D, Lipman RD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:45-53

Published Date: 12 February 2014

Review

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate

Sweeting AN, Tabet E, Caterson ID, Markovic TP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:35-44

Published Date: 12 February 2014

Review

Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes

Montane J, Cadavez L, Novials A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:25-34

Published Date: 3 February 2014

Review

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated

Irons BK, Minze MG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:15-24

Published Date: 18 January 2014

Original Research

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:1-14

Published Date: 21 December 2013

Original Research

Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin

Jurczyk A, diIorio P, Brostowin D, Leehy L, Yang C, Urano F, Harlan DM, Shultz LD, Greiner DL, Bortell R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:493-499

Published Date: 13 December 2013

Review

HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?

Kowall B, Rathmann W

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:477-491

Published Date: 29 November 2013

Original Research

The effects of diet- and diet plus exercise-induced weight loss on basal metabolic rate and acylated ghrelin in grade 1 obese subjects

Lopes AL, Fayh AP, Campos LG, Teixeira BC, Carteri RBK, Ribeiro JL, Friedman R, Reischak-Oliveira A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:469-475

Published Date: 29 November 2013

Review

SGLT-2 inhibitors and their potential in the treatment of diabetes

Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:453-467

Published Date: 27 November 2013

Original Research

Effects of a recreational physical activity and healthy habits orientation program, using an illustrated diary, on the cardiovascular risk profile of overweight and obese schoolchildren: a pilot study in a public school in Brasilia, Federal District, Brazil

Militão AG, Karnikowski MGO, Silva FR, Militão ESG, Pereira RMS, Campbell CSG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:445-451

Published Date: 27 November 2013

Review

Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes

Stolar MW, Grimm M, Chen S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:435-444

Published Date: 22 November 2013

Original Research

Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans

Nakanishi S, Yoneda M, Maeda S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:427-433

Published Date: 22 November 2013

Review

Importance of family/social support and impact on adherence to diabetic therapy

Miller TA, DiMatteo MR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:421-426

Published Date: 6 November 2013

Review

Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis

Savva SC, Lamnisos D, Kafatos AG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:403-419

Published Date: 24 October 2013

Short Report

The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review

Rolland C, Mavroeidi A, Johnston KL, Broom J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:393-401

Published Date: 11 October 2013

Original Research

Evaluation of the maximum beyond-use-date stability of regular human insulin extemporaneously prepared in 0.9% sodium chloride in a polyvinyl chloride bag

Rocchio MA, Belisle CD, Greenwood BC, Cotugno MC, Szumita PM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:389-392

Published Date: 11 October 2013

Review

Hepatic function and the cardiometabolic syndrome

Wiernsperger N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:379-388

Published Date: 10 October 2013

Original Research

Socioeconomic status and obesity in Abia State, South East Nigeria

Chukwuonye II, Chuku A, Okpechi IG, Onyeonoro UU, Madukwe OO, Okafor GOC, Ogah OS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:371-378

Published Date: 16 October 2013

Original Research

Radiographic evaluation of the effect of obesity on alveolar bone in rats with ligature-induced periodontal disease

do Nascimento CM, Cassol T, da Silva FS, Bonfleur ML, Nassar CA, Nassar PO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:365-370

Published Date: 7 October 2013

Commentary

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment

Scott D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:359-363

Published Date: 2 October 2013

Review

Systematic review of clinical studies related to pork intake and metabolic syndrome or its components

Stettler N, Murphy MM, Barraj LM, Smith KM, Ahima RS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:347-357

Published Date: 25 September 2013

Original Research

Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study

Bonet J, Martinez-Castelao A, Bayés B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:339-346

Published Date: 18 September 2013

Review

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review

Colosia AD, Palencia R, Khan S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:327-338

Published Date: 17 September 2013

Review

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus

Konya H, Katsuno T, Tsunoda T, Yano Y, Kamitani M, Miuchi M, Hamaguchi T, Miyagawa JI, Namba M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:317-325

Published Date: 2 September 2013

Original Research

Effects of a leucine and pyridoxine-containing nutraceutical on body weight and composition in obese subjects

Zemel MB, Bruckbauer A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:309-315

Published Date: 23 August 2013

Original Research

Treatment outcome and prognostic indices in patients with hyperglycemic emergencies

Ezeani IU, Eregie A, Ogedengbe OS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:303-307

Published Date: 19 August 2013

Original Research

Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction

Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:293-301

Published Date: 13 August 2013

Original Research

Prevalence of abdominal obesity in Abia State, Nigeria: results of a population-based house-to-house survey

Chukwuonye II, Chuku A, Onyeonoro UU, Okpechi IG, Madukwe OO, Umeizudike TI, Ogah OS

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:285-291

Published Date: 1 August 2013

Original Research

Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study

Usharani P, Fatima N, Muralidhar N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:275-284

Published Date: 26 July 2013

Original Research

Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial

Cuevas-Ramos D, Almeda-Valdés P, Chávez-Manzanera E, Meza-Arana CE, Brito-Córdova G, Mehta R, Pérez-Méndez O, Gómez-Pérez FJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:263-273

Published Date: 26 July 2013

Short Report

Effect of calcium channel blockers on incidence of diabetes: a meta-analysis

Noto H, Goto A, Tsujimoto T, Noda M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:257-261

Published Date: 26 July 2013

Original Research

Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials

Yang F, Ye J, Pomerantz K, Stewart M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:247-256

Published Date: 12 July 2013

Rapid Communication

Association of FTO and PPARG polymorphisms with obesity in Portuguese women

Ferreira Carlos F, Silva-Nunes J, Flores O, Brito M, Doria G, Veiga L, Baptista PV

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:241-245

Published Date: 11 July 2013

Review

Evidence for the benefit of exercise therapy in patients with type 2 diabetes

Madden KM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:233-239

Published Date: 3 July 2013

Review

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus

Petersen AB, Christensen M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:217-231

Published Date: 17 June 2013

Review

Lorcaserin for weight management

Taylor JR, Dietrich E, Powell J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:209-216

Published Date: 13 June 2013

Review

Management of limited joint mobility in diabetic patients

Abate M, Schiavone C, Salini V, Andia I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:197-207

Published Date: 7 May 2013

Review

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes

Kishimoto M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:187-195

Published Date: 6 May 2013

Original Research

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

Ostenson CG, Matthaei S, Reaney M, Krarup T, Guerci B, Kiljanski J, Salaun-Martin C, Sapin H, Bruhn D, Mathieu C, Theodorakis M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:171-185

Published Date: 26 April 2013

Review

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

Russo E, Penno G, Del Prato S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:161-170

Published Date: 24 April 2013

Review

Predictors and prevention of diabetic cardiomyopathy

Chavali V, Tyagi SC, Mishra PK

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:151-160

Published Date: 11 April 2013

Original Research

An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco

Shihabi AR, Moussa EM, Sobierajska H, Schmidt B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:141-150

Published Date: 9 April 2013

Review

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity

Shin JH, Gadde KM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:131-139

Published Date: 8 April 2013

Original Research

Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience

Anichini R, Cosimi S, Di Carlo A, Orsini P, De Bellis A, Seghieri G, Franconi F, Baccetti F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:123-129

Published Date: 8 April 2013

Review

The impact of brief high-intensity exercise on blood glucose levels

Adams OP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:113-122

Published Date: 27 February 2013

Original Research

Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure

Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Kashtalap V, Barbarash O

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:103-111

Published Date: 18 February 2013

Original Research

Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity

Bruckbauer A, Zemel MB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:93-102

Published Date: 13 February 2013

Original Research

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

Sadosky A, Schaefer C, Mann R, Bergstrom F, Baik R, Parsons B, Nalamachu S, Nieshoff E, Stacey BR, Anschel A, Tuchman M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:79-92

Published Date: 8 February 2013

Review

Guidelines in the management of diabetic nerve pain clinical utility of pregabalin

Vinik AI, Casellini CM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:57-78

Published Date: 22 February 2013

Original Research

Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity

Kumar R, Chhatwal S, Arora S, Sharma S, Singh J, Singh N, Bhandari V, Khurana A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:49-56

Published Date: 19 January 2013

Review

Prevalence of overweight and obesity in adult Nigerians – a systematic review

Chukwuonye II, Chuku A, John C, Ohagwu KA, Imoh ME, Isa SE, Ogah OS, Oviasu E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:43-47

Published Date: 22 January 2013

Original Research

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years

MacConell L, Pencek R, Li Y, Maggs D, Porter L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:31-41

Published Date: 21 January 2013

Review

Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review

Holmes C, Wrobel JS, MacEachern MP, Boles BR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:17-29

Published Date: 17 January 2013

Original Research

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus

Feher M, Greener M, Munro N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:11-15

Published Date: 10 January 2013

Review

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes

Gallwitz B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:1-9

Published Date: 4 January 2013

Original Research

Association of lipid profile and waist circumference as cardiovascular risk factors for overweight and obesity among school children in Qatar

Rizk NM, Yousef M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:425-432

Published Date: 20 December 2012

Original Research

Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes

Malloy J, Gurney K, Shan K, Yan P, Chen S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:419-424

Published Date: 17 December 2012

Review

Social support in type II diabetes care: a case of too little, too late

Kadirvelu A, Sadasivan S, Ng SH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:407-417

Published Date: 22 November 2012

Original Research

Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico

García-Alcalá H, Genestier-Tamborero CN, Hirales-Tamez O, Salinas-Palma J, Soto-Vega E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:403-406

Published Date: 19 November 2012

Original Research

Obstructive sleep apnea and bone mineral density in obese patients

Mariani S, Fiore D, Varone L, Basciani S, Persichetti A, Watanabe M, Saponara M, Spera G, Moretti C, Gnessi L

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:395-401

Published Date: 7 November 2012

Original Research

Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study

Strassnig M, Brar JS, Ganguli R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:389-394

Published Date: 26 October 2012

Review

Screening strategies and predictive diagnostic tools for the development of new-onset diabetes mellitus after transplantation: an overview

Pham PT, Edling KL, Chakkera HA, Pham PC, Pham PM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:379-387

Published Date: 26 October 2012

Original Research

Association of ADIPOQ +45T>G polymorphism with body fat mass and blood levels of soluble adiponectin and inflammation markers in a Mexican-Mestizo population

Guzman-Ornelas MO, Chavarria-Avila E, Munoz-Valle JF, Armas-Ramos LE, Castro-Albarran J, Aguilar Aldrete ME, Oregon-Romero E, Vazquez-Del Mercado M, Navarro-Hernandez RE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:369-378

Published Date: 17 October 2012

Review

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations

Rosak C, Mertes G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:357-367

Published Date: 12 October 2012

Original Research

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults

Da Costa LA, Arora P, García-Bailo B, Karmali M, El-Sohemy A, Badawi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:347-355

Published Date: 4 October 2012

Original Research

Atherosclerosis and atherosensitivity in two southwest Algerian desert rodents, Psammomys obesus and Gerbillus gerbillus, and in Rattus norvegicus

El-Aoufi S, Lazourgui MA, Griene L, Maouche B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:337-345

Published Date: 18 September 2012

Review

Nutritional therapy for the management of diabetic gastroparesis: clinical review

Sadiya A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:329-335

Published Date: 7 September 2012

Review

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes

Kim Y, Babu AR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:313-327

Published Date: 31 August 2012

Original Research

Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetes

Eckert K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:303-311

Published Date: 23 August 2012

Review

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes

Hoimark L, Laursen T, Rungby J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:295-302

Published Date: 23 August 2012

Letter

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Al Sifri S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:293-294

Published Date: 15 August 2012

Original Research

Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes: a 12-month intervention

Haimoto H, Sasakabe T, Umegaki H, Wakai K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:283-291

Published Date: 13 August 2012

Review

Microvesicles/exosomes as potential novel biomarkers of metabolic diseases

Müller G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:247-282

Published Date: 7 August 2012

Original Research

Six-minute walk test in non-insulin-dependent diabetes mellitus patients living in Northwest Africa

Latiri I, Elbey R, Hcini K, Zaoui A, Charfeddine B, Maarouf MR, Tabka Z, Zbidi A, Ben Saad H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:227-245

Published Date: 7 August 2012

Original Research

Prediction of insulin resistance with anthropometric measures: lessons from a large adolescent population

Wedin WK, Diaz-Gimenez L, Convit AJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:219-225

Published Date: 23 July 2012

Short Report

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:213-217

Published Date: 17 July 2012

Original Research

Right Diet: a television series to combat obesity among adolescents in Kuwait

Al-Haifi AR, Al-Fayez MA, Al-Nashi B, Al-Athari BI, Bawadi H, Musaiger AO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:205-212

Published Date: 6 July 2012

Review

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review

Wang F, Surh J, Kaur M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:191-204

Published Date: 5 July 2012

Hypothesis

Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity

Spreadbury I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:175-189

Published Date: 6 July 2012

Review

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review

Berlie H, Hurren KM, Pinelli NR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:165-174

Published Date: 3 July 2012

Original Research

Pentosidine levels in nonproteinuric diabetes associated with both low estimated glomerular filtration rate and cataract

Lim XL, Teo BW, Tai BC, Wong TY, Ng DP

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:155-164

Published Date: 29 June 2012

Original Research

Glucose estimation in the salivary secretion of diabetes mellitus patients

Abikshyeet P, Ramesh V, Oza N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:149-154

Published Date: 12 July 2012

Review

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus

Whaley JM, Tirmenstein M, Reilly TP, Poucher SM, Saye J, Parikh S, List JF

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:135-148

Published Date: 23 July 2012

Original Research

Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients

Bays HE

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:125-134

Published Date: 28 May 2012

Letter

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects

Kapoor S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:121-123

Published Date: 11 May 2012

Review

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

AlMaatouq MA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:109-119

Published Date: 1 May 2012

Review

Clinical features and treatment of maturity onset diabetes of the young (MODY)

Gardner DS,Tai ES

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:101-108

Published Date: 1 May 2012

Review

Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

Dincer UD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:89-99

Published Date: 5 April 2012

Review

Obesity: considerations about etiology, metabolism, and the use of experimental models

Pereira-Lancha LO, Campos-Ferraz PL, Lancha Junior AH

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:75-87

Published Date: 10 April 2012

Review

Uncovering undetected hypoglycemic events

Unger J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:57-74

Published Date: 8 March 2012

Original Research

Negative association of acetate with visceral adipose tissue and insulin levels

Layden BT, Yalamanchi SK, Wolever TMS, Dunaif A, Lowe Jr WL

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:49-55

Published Date: 28 February 2012

Short Report

Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice

Nikoulina SE, Fuchs D, Moheno P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:43-47

Published Date: 24 February 2012

Original Research

Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials

MacConell L, Brown C, Gurney K, Han J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:29-41

Published Date: 20 February 2012

Original Research

Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects

Vinson JA, Burnham BR, Nagendran MV

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:21-27

Published Date: 18 January 2012

Review

Insulin detemir for the treatment of obese patients with type 2 diabetes

Hollander PA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:11-19

Published Date: 10 January 2012

Review

Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations

Uy J, Fogelfeld L, Guerra Y

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2012, 5:1-10

Published Date: 10 January 2012

Methodology

Arab Teens Lifestyle Study (ATLS): objectives, design, methodology and implications

Al-Hazzaa HM, Musaiger AO; ATLS Research Group

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:417-426

Published Date: 20 December 2011

Original Research

Effect of Ramadan fasting on metabolic markers, body composition, and dietary intake in Emiratis of Ajman (UAE) with metabolic syndrome

Sadiya A, Ahmed S, Siddieg HH, Babas IJ, Carlsson M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:409-416

Published Date: 15 December 2011

Original Research

Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy

Taylor-Stokes G, Pike J, Sadosky A, Chandran A, Toelle T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:401-408

Published Date: 5 December 2011

Original Research

Comparison of demographic and clinical characteristics influencing health-related quality of life in patients with diabetic foot ulcers and those without foot ulcers

Yekta Z, Pourali R, Ghasemi-rad M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:393-399

Published Date: 2 December 2011

Original Research

Resistance training associated with the administration of anabolic-androgenic steroids improves insulin sensitivity in ovariectomized rats

Urtado CB, Pereira GB, Urtado MB, Carvalho EB, Leite GS, Donatto FF, Assumpção CO, Leite RD, Silva CA, Sales MM, Tibana RA, Alves SCC, Prestes J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:385-391

Published Date: 22 November 2011

Original Research

Glycemic control and anti-osteopathic effect of propolis in diabetic rats

Al-Hariri M, Gamal Eldin T, Abu-Hozaifa B, Elnour A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:377-384

Published Date: 22 November 2011

Original Research

Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer

Yekta Z, Pourali R, Nezhadrahim R, Ravanyar L, Ghasemi-rad M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:371-375

Published Date: 13 October 2011

Review

Management of diabetes across the course of disease: minimizing obesity-associated complications

Apovian CM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:353-369

Published Date: 12 October 2011

Original Research

Morning cortisol is lower in obese individuals with normal glucose tolerance

Praveen EP, Sahoo JP, Kulshreshtha B, Khurana ML, Gupta N, Dwivedi SN, Kumar G, Ammini AC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:347-352

Published Date: 7 September 2011

Review

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach

Kedia N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:337-346

Published Date: 6 September 2011

Review

Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist?

Alexandrescu V, Hubermont G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:327-336

Published Date: 22 August 2011

Corrigendum

Corrigendum

Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:325-326

Published Date: 17 August 2011

Original Research

Effect of weight loss on adipokine levels in obese patients

Rolland C, Hession M, Broom I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:315-323

Published Date: 3 August 2011

Original Research

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:307-313

Published Date: 2 August 2011

Review

Update on the management of diabetic polyneuropathies

Shakher J, Stevens MJ

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:289-305

Published Date: 21 July 2011

Original Research

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring

Abe S, Inoue G, Yamada S, Irie J, Nojima H, Tsuyusaki K, Usui K, Atsuda K, Yamanouchi T

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:283-288

Published Date: 13 July 2011

Review

Is obesity in women protective against osteoporosis?

Migliaccio S, Greco EA, Fornari R, Donini LM, Lenzi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:273-282

Published Date: 4 July 2011

Review

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes

Derosa G, Maffioli P

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:263-271

Published Date: 30 June 2011

Review

Insulin initiation and intensification in patients with T2DM for the primary care physician

Unger J

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:253-261

Published Date: 28 June 2011

Original Research

Perception of weight and psychological variables in a sample of Spanish adolescents

Jáuregui-Lobera I, Bolaños-Ríos P, Santiago-Fernández MJ, Garrido-Casals O, Sánchez E

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:245-251

Published Date: 24 June 2011

Review

Predictors of weight loss and maintenance in patients treated with antiobesity drugs

Guaraldi F, Pagotto U, Pasquali R

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:229-243

Published Date: 20 June 2011

Original Research

Central adiposity and the propensity for rehearsal in children

Ling FCM, Masters RSW, Yu CCW, McManus AM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:225-228

Published Date: 17 June 2011

Original Research

Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton

Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:213-223

Published Date: 16 June 2011

Original Research

Is vitamin D status a determining factor for metabolic syndrome? A case-control study

Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:205-212

Published Date: 10 June 2011

Original Research

Diet-induced metabolic hamster model of nonalcoholic fatty liver disease

Bhathena J, Kulamarva A, Martoni C, Urbanska A, Malhotra M,  Paul A, Prakash S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:195-203

Published Date: 3 June 2011

Original Research

Cardiometabolic results from an armband-based weight loss trial

Sieverdes JC, Sui X, Hand GA, Barry VW, Wilcox S, Meriwether RA, Hardin JW, McClain AC, Blair SN

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:187-194

Published Date: 30 May 2011

Review

New onset diabetes after transplantation (NODAT): an overview

Pham PT, Pham PM, Pham SV, Pham PA, Pham PC

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:175-186

Published Date: 9 May 2011

Original Research

Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes

Sasakabe T, Haimoto H, Umegaki H, Wakai K

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:167-174

Published Date: 29 April 2011

Review

Treating statin-intolerant patients

Arca M, Pigna G

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:155-166

Published Date: 28 April 2011

Review

Strategies for reducing body fat mass: effects of liposuction and exercise on cardiovascular risk factors and adiposity

Benatti FB, Lira FS, Oyama LM, Oller do Nascimento CM, Lancha AH Jr

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:141-154

Published Date: 20 April 2011

Original Research

Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice

Talba T, Shui XW, Cheng QY, Tian X

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:137-140

Published Date: 18 April 2011

Original Research

Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes

Stack RJ, Bundy C, Elliott RA, New JP, Gibson JM, Noyce PR

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:127-135

Published Date: 11 April 2011

Original Research

Relationship between sleep duration and clustering of metabolic syndrome diagnostic components

Katano S, Nakamura Y, Nakamura A, Murakami Y, Tanaka T, Takebayashi T, Okayama A, Miura K, Okamura T, Ueshima H

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:119-125